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1. INTRODUCTION
1.1. Historical overview of antibiotics 
The antibiotics  field  was initiated  when Paul  Ehrlich  first  coined the  term
‘magic bullet’, or chemotherapy, to designate the use of antimicrobial compounds to
treat  microbial  infections.  In  1910,  Ehrlich  discovered  the  first  antibiotic  drug,
Salvarsan,  which  was  used  against  syphilis.  Ehrlich  was  followed  by  Alexander
Fleming, who discovered penicillin by accident in1928. Then, in the 1935, Gerhard
Domagk discovered the sulfa drugs, thereby paving the way to the discovery of the
anti-TB drug Isoniazid.  Then,  in  1939 Rene Dobos  became then  first  scientist  to
discover  an  antibiotic  after  purposely  looking  for  it  in  soil  microbes.  Dubos
discovered Gramicidin, which is still used today to treat skin infections. Finally, in
1943,  the  first  TB drug,  Streptomycin,  was  discovered  by Selman  Waksman  and
Albert schatz. Waksman was also the one who coined the term ‘antibiotics’. Thus,
antibiotics have been used to treat bacterial infections since the 1940(Ying Zhang
Baltimore2007,USA))
  1.2 Antibiotic
An antibiotic  is  an  agent  produced  by  a  microbe,  such  as  a  fungus  or  a
bacterium,  that  kills  or  slows  the  growth  of  other  microorganisms,  particularly
bacteria. An antibiotic is a type of antimicrobial drug. Antibiotics are used to treat
bacterial illnesses like ear infections and strep throat. Antibiotics and antimicrobial
drugs are  also  used to  treat  or  prevent  illnesses  in  animals  and in  other  areas  of
agriculture.  Antimicrobial  agents  are also found in many of  the cleaning products
marketed  today.  The  use  of  antimicrobial  agents  can  lead  to  the  development  of
antimicrobial resistance in microbes exposed to them. (Richard C. Honour 2003)
1.3. The Basic Characteristics of Antibiotics 
Today, there are about 4000 compounds with antibiotic properties. Antibiotics
are used to treat and prevent infections, and to promote growth in animals. Antibiotics
are  derived  from  three  sources:  moulds  or  fungi;  bacteria;  or  synthetic  or  semi-
synthetic  compounds.  They  can  be  used  either  internally  or  topically,  and  their
function is to either inhibit the growth of pathogens or to kill them. Antibiotics can
thus  be divided  into Bacteriostatic  drugs,  which  merely inhibit  the growth  of  the
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pathogen,  and  Bacteriocidal  drugs,  which  actually  kill  the  bacteria.  However,  the
distinction  is  not  absolute,  and  depends  on  the  drug  concentration,  the  bacterial
species,  and  the  phase  of  growth.  Antibiotics  are  more  effective  against  actively
growing  bacteria,  than  against  non-growing  per  sisters  or  spores.  When  two
antibiotics  are  used  in  combination,  the  effect  could  be  additive,  synergistic,  or
antagonistic.  Antibiotics  can  also  be  divided  into  broad-spectrum  and  narrow-
spectrum antibiotics. For example, Tetracycline, a broad spectrum antibiotic, is active
against G+ bacteria, G bacteria, and even against mycobacteria; whereas penicillin,
which has a  relatively narrow spectrum, can be used mainly against  G+ bacteria.
Other antibiotics, such as Pyrazinamide, have an even narrower spectrum, and can be
used merely against Mycobacterium tuberculosis.Antibiotics fight against bacteria by
inhibiting certain  vital  processes  of  bacterial  cells  or  metabolism.  Based  on these
processes, we can divide antibiotics into five major classes:
1. Cell wall inhibitors, such as Penicillin and Vancomycin.
2. Inhibitors of nucleic acid synthesis, such as Fluoroquinolones, which inhibits
DNA synthesis, and rifampin, which inhibits RNA synthesis.
3. Protein synthesis inhibitors, such as Amino glycoside.
4. Anti-metabolites, such as sulfa drugs.
5. Antibiotics that can damage the membrane of the cell, such as Polymyxin B,
Gramicidin and Daptomyc in (YingZhang Baltimore2007,
USA)
1.4. The Origin of Antibiotic Resistance 
Although it  is  difficult  to know for certain,  the absolute original  source of
antibiotic resistance may be the bacteria themselves that produced the antibiotics in
the  first  place.  Within  the  microbial  world  there  is  the  concept  of  microbial
antagonism, where by each kind or species of bacteria is in direct competition for
nutrients  and  space  with  other  microbes.  Somewhere  in  the  process,  bacteria
developed chemical defenses against their competitors, and today we refer to those
chemicals as antibiotics. ( Richard C. Honour  2003 )
Nearly all  microbes,  and  even  higher  organisms,  such  as  algae,  fungi  and
higher plants, all make chemicals to overcome or otherwise control the competition. It
was the early observations of ‘zones of inhibition’ in the growth patterns of bacteria
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on the surfaces of Petri plates caused by moulds that provided the observations. And
historically, organic soils, peat, humus, mosses and moulds of many kinds were used
in natural and historical medicine to treat infections. Those organic materials used in
traditional  medicine  all  harbored  microbes  that  produced  chemical  antibiotics.
( Richard C. Honour  2003 )
1.5. Types of antibiotic resistance
            There are three types of resistance: natural (intrinsic or innate), acquired and
mutational.(Ashraf,R and Shah,N,P 2011)
1.6. The Rise of Antibiotic-Resistant Infections
When penicillin became widely available during the second world war, it was
a medical miracle, rapidly vanquishing the biggest wartime killer--infected wounds.
Discovered initially by a French medical student, Ernest Duchesne, in 1896, and then
re discovered by Scottish physician Alexander Fleming in 1928, the product of the
soil mold Penicillium crippled many types of disease-causing bacteria. But just four
years after drug companies  began mass-producing Penicillin in 1943, microbes began
appearing that could resist it. (Ricki Lewis 1995)
The first bug to battle penicillin was Staphylococcus aureus. This bacterium is
often  a  harmless  passenger  in  the  human  body,  but  it  can  cause  illness,  such  as
pneumonia or toxic shock syndrome, when it overgrows or produces a toxin.
In  1967,  another  type  of  penicillin-resistant  pneumonia,  caused  by
Streptococcus pneumoniae and called Pneumococcus, surfaced in a remote village in
Papua New Guinea. At about the same time, American military personnel in Southeast
Asia were acquiring penicillin-resistant Gonorrhea from prostitutes.  By 1976, when
the soldiers had come home, they brought the new strain of Gonorrhea with them, and
physicians had to find new drugs to treat it. In 1983, a hospital-acquired intestinal
infection caused by the bacterium Enterococcus faecium joined the list of bugs that
outwit penicillin.
Antibiotic resistance spreads fast. Between 1979 and 1987, for example, only
0.02 percent of Pneumococcus strains infecting a large number of patients surveyed
by the National Centers for Disease Control and Prevention (CDC) were Penicillin-
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resistant.  CDC's  survey included  13  hospitals  in  12  states.  Today,  6.6  percent  of
pneumococcus strains are resistant, according to a report in the June 15, 1994, Journal
of the American Medical Association by Robert F.Breiman, M.D., and colleagues at
CDC. The agency also reports that in 1992, 13,300 hospital patient died of bacterial
infection that were resistant to antibiotic treatment.( Ricki Lewis 1995)
1.7. Antibiotic Resistance or Antibiotic resistance by microbes
Antibiotic  resistance  has  developed  as  a  natural  evolutionary  response  of
bacteria  following  their  exposure  to  these  drugs  and  is  defined  as  the  ability  of
bacteria to withstand the inhibition concentration of an antibiotic. It can be intrinsic
(naturally occurring) or acquired. The first type is defined as resistance characteristic
for all members of a given bacterial species or genus. It results from an inability of the
antibiotic to reach its target, a lack of affinity for the target, the presence of efflux
pumps  or  possession  of  other  chromosomal  resistance  mechanisms  (Magdalena
Chroma 2010)
Antibiotic resistance is recognized as being one of measures to prevent,  or
contain, the increase in antibiotic resistant organisms requires knowledge of both the
genesis  of  an  antibiotic  resistance  genes  and their  dissemination.  The problem of
antibiotic resistance affects almost every bacterial species for which treatment with
antibiotics is available (Adel Kk and Sabiha,S.S 2010)
Resistant bacteria are not as susceptible to antibiotics as non-resistant bacteria.
The use of antibiotics may eliminate susceptible bacteria, leaving resistant bacteria
behind. If resistant bacteria spread, a person or animal with this infection may not be
able to be treated with the usual antibiotics, or an increased dose may be required. As
a result, they may be sick for a longer time than if they had an infection caused by
bacteria that were easily treatable with antibiotics. (Richard C. Honour 2003)
1.8. Development of Resistance
The increase in bacterial antimicrobial resistance is a natural phenomenon, an
outcome of  evolution.  Any population  of  organisms,  including  bacteria,  naturally
includes variants with unusual traits. In this case, some bacteria have the ability to
fend  off  the  action  of  an  antimicrobial  agent.  The  use  of  antimicrobial  drugs  in
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humans  and  animals  over  the  past  50  years  has  inadvertently  accelerated  the
development  of  resistance  by  increasing  the  selective  pressure  exerted  on  these
organisms.  Once antimicrobial  pressure  has  been  introduced  into  an environment,
resistance may be spread to other microbes. Food animals, such as cattle, pigs, turkeys
or chikens,  may receive  antimicrobial  drugs  for  growth  promotion and control  or
treatment of infectious diseases. 
Food animals can carry organisms that can make people sick,  but may not
necessarily make the animal sick. For example,  Salmonella, Campylobacter and E.
coli are  common bacteria  found in  the  intestines  of  various  food  animals.  These
bacteria  may  not  cause  disease  in  the  animal,  but  all  three  bacteria  may  cause
foodborne illness in humans. These organisms may develop resistance when exposed
to antibiotics given to the animal. These resistant organisms can contaminate food
products at slaughter and then infect humans who eat the food, particularly if the food
is undercooked or contaminated after cooking. Evidence of increasing resistance to
antimicrobial drug treatment in bacteria that infect humans has raised questions about
the  role  that  antimicrobial  drug  use  in  food  animals  plays  in  the  emergence  of
antimicrobial  drug  resistant  bacteria.  The  link  between  antimicrobial  resistance  in
foodborne pathogenic bacteria  and use of antimicrobials in food animals has been
reported in a number of studies. For foodborne pathogens, especially those such as
Salmonella that are rarely transferred from person to person in the US, food (such as
meat or eggs) from food animals is considered a likely source of most antimicrobial
resistance (Richard C. Honour2003)
1.9. Causes for Drug Resistance
One of the main causes of antibiotics drug resistance is antibiotic overuse,
abuse,  and  in  some  cases,  misuse,  due  to  incorrect  diagnosis.  A second  cause  is
counterfeit drugs. Antibiotic use Antibiotic use in animal husbandry is also creating
some  drug  resistant  bacteria,  which  can  be  transmitted  to  humans.  Increased
globalisation could also cause the spread of drug resistance. Finally, hospital settings
often give rise to antibiotic resistant bacteria.( Ying ZHANG Baltimore, 2007.USA)
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1.10. Prevent the Spread of Antimicrobial Resistance
• Unless  otherwise  bacterial  persist  Antibiotic  treatment  may  be  avoided  to
relieve the symptoms
• Exact medication given by prescription need to be taken 
• Entire course of antibiotic must be taking even if relief from symptoms.
• Repetition of same medication need to be avoided (Richard C. Honour 2003)
1.11. Possible mechanisms involved in antibiotic resistance
Bacteria may manifest resistance to antibacterial drugs through a variety of
mechanisms.  Some  species  of  bacteria  are  innately  resistant  to  1st class  of
antimicrobial agents. In such cases, all strains of that bacterial species are likewise
resistant to all the members of those antibacterial classes of greater concern are cases
of  acquired  resistance,  where  initially  susceptible  populations  of  bacteria  become
resistant  to  an  antibacterial  agent  and  proliferate  and  spread  under  the  selective
pressure of use of that agent. (yingzhang 2007) Several mechanisms of antimicrobial
resistance are readily spread to a variety of bacterial genera.  There are five major
mechanisms of antibiotic drug resistance, which are due to chromosomal mutations:
 Reduced permeability or uptake.
 Efflux pump
 Enzymatic inactivation.
 Alteration of the drug target.
 Loss of  enzyme in  drug activation (Magdalena  Chroma 2010.  Ying Zhang
Baltimore 2007, USA).
a. Reduced Permeability or Uptake
The first  mechanism is reduced permeability or uptake of the bacteria.  For
example, Neisseria gonorrhoea porin can acquire mutations that can cause resistance
to  penicillin  and  tetracycline.  Another  example  is  Enterobacter  aerogenes porin,
which can acquire mutations that cause cephalosporin resistance.
b. Increased Efflux Activity
             Efflux pumps are transmembrane transport proteins, used physiologically in
Gram positive  and  Gram-negative  bacteria  for  exporting  specific  metabolites  and
xenobiotic toxic substances out of the cell. As an energy source they utilize the proton
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motive force.  Pumps may be specific for one substrate or may transport arrange of
trructurally  different  compounds  (including  multiple  antibiotics);  such  transport
proteins  can  be  associated  with  multiple  drug  resistance.  Tetracycline  pumps  are
probably the  best  studied  efflux  system in  both  Gram-positive  and  Gramnegative
bacteria. (Magdalena  Chroma et al 2010)
There are many examples of the second mechanism, increased efflux activity.
The first one, Tetracycline efflux was discovered in the early 1980s. TetK serves as an
example for an efflux-mediated Tetracycline resistance. Under normal conditions, the
efflux gene, TetK, is not expressed, due to a suppressor that is bound to the promoter
region. However, in the presence of Tetracycline, it binds to the repressor, relieves the
suppression,  and  causes  transcription  and  translation  of  the  efflux  pump,  thereby
leading to Tetracycline resistance.( Ying Zhang Baltimore 2007).
c. Enzymatic Inactivation
A famous example of the third mechanism, enzymatic inactivation, is Beta-
lactamases, which can cleave beta-lactam antibiotics and cause resistance. A second
example is the Aminoglycoside-inactivating enzymes, which can add Acetyl, Adenyl,
and  Phosphoryl  groups  to  inactivate  the  antibiotic.  Finally,  both  Chloramphenicol
Acetyl Transferase and Streptogramin Acetyl Transferase can add an acetyl group to
inactivate the two antibiotics, respectively.
d. Alteration of Drug Target
An example close to home to the alteration or over-expression of the drug
target  is  InhA.  This  promoter  mutation  causes  over-expression  of  the  drug  target
InhA, and lead to a low-level isoniazid (INH) resistance in M. tuberculosis. A second
noteworthy example is penicillin resistance, which is due to alterations in penicillin
binding  proteins.  A  third  example  is  vancomycin  resistance.  Under  susceptible
conditions, vancomycin prevents cross-linking of peptidoglycan by binding to D-Ala-
D-Ala  dipeptide  of  the  muramylpeptide.  Most  G+  bacteria  acquire  vancomycin
resistance  by  changing  D-Ala-D-Ala  to  DAla-D-lactate,  which  does  not  bind  to
vancomycin.  A fourth example  is  mutations  in  DNA gyrase  A and  B subunits  in
quinolone resistance is another example of an alteration of the drug target. Finally, in
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Rifampicin  resistance,  there  are  mutations  in  rpoB  gene encoding beta-subunit  of
RNA polymerase.
e. Loss of Enzymes in Drug Activation
Loss of enzymes involved in drug activation is a relatively new mechanism of
drug resistance. In this case, the antibiotic itself is a prodrug, which has no direct
activity  against  the  bacteria.  Rather,  it  relies  on  the  activation  by  a  bacterial
enzyme.INH can serve as a useful example. KatG (catalase-peroxidase) is an enzyme
involved in the activation of INH, which produces a range of reactive metabolites
including  reactive  oxygen  species  and  then  reactive  organic  radicals,  which  then
inhibit  multiple  targets,  including mycolic  acid  synthesis.  Another  example  is  the
Metronidazole (MTZ) prodrug. MTZ is activated through RdxA (nitroreductase), and
then forms reactive species that damage the DNA. Thus, mutations in this enzyme
cause resistance to Metronidazole.
1.12. Experimental  studies supporting determination of  bacterial
resistance
1.12.1. Minimum inhibitory concentration
MIC was defined as the lowest concentration of antibiotics that produced no
growth  Minimum  Inhibitory  Concentration  (MIC)  (lowest  concentration  of  an
antimicrobial agent that inhibits growth of microorganism after overnight incubation
(Amin etal 2009)
1.12.2. Transformation 
One bacterium may take up DNA from another, either as a single gene or more
often as cassettes of genes, which are then spliced into the chromosome of the new
host  bacterium.  Bacteriophage  viruses  also  transfer  DNA from  one  bacterium  to
another, sometimes among bacteria of the same species and sometimes across Genera.
(Richard C. Honour2003)
1.12.3. Plasmid DNA
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Small  circular forms of DNA called plasmids.  Plasmids carrying resistance
genes may be exchanged between bacteria of different species or types. (Richard C.
Honour2003)
            Plasmids are most replicating circular pieces of DNA, smaller than the
bacterial genome which encoded their transfer by replication into another bacterial
strain or species. They can carry and transfer multiple resistance genes, which may be
located on section of DNA capable of transfer from one plasmid to another or to the
genome-transposon or jumping gene (Adel Kk and  Sabiha,S.S 2010) 
1.12.4. Competence cell 
Natural  competence  is  a  genetically  programmed  physiological  state
permitting the efficient uptake of macromolecular DNA. It is distinct from artificial
transformation  involving  electroporation,  protoplasts,  and  heat  shock/CaCl2
treatment. In many bacteria, competence is highly regulated, and much research has
been devoted to exploring the complex control mechanisms involved. ( David Dubnau
1999 )
1.12.5. Efflux pump
Efflux  pumps  are  transports  proteins  involved  in  the  extrutions  of  toxic
substrate (including virtually all classes of relevant antibiotics) from within the cells
into  the  external  environment.these  proteins  are  found in  both  Gram-positive  and
Gram-negative bacteria as well as in eukaryotic organism. Pump may be specific for
one substrate  or  transport  a  range  of  structurally dissimilar  compounds (including
antibiotic  of  multiple  classes),  such  pump  can  be  associate  with  multiple  drug
resistance MDR. In the prokaryotic kingdom there are five major families of efflux
transporters  MF  (Major  facilitator),MATE  (mutidrug  and  toxic  efflux),  RND
(resistance –nodulation-division), SMR (small mutidrug resistance), and ABC (ATP
binding cassette). All these system utilize the proton motive force as an energy, apart
from the ABC family, which utilize ATP hydrolysis to drive the export of substrates.
(Webber M.A. and Piddock L.J.V. 2003)
1.12.6. Necessity to determine the resistance
 To prevent increase in antibiotic resistance,
 To prevent/contain spread of infection,
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 To find out alternative drug by understanding the Mechanisms. So the current
study  focused  to  necessity  to  determination  resistance  bacteria,  and  its
mechanism.  The  scope  existent  in  development  of  new  antibiotic  and
prevention of spread specific resistance. (adel k.k et al 2010)
2. LITERATURE REVIEW
Lazaroaie MM 2009 stated that the high world interest given to the researches
concerning the study of moderately halophilic solvent-tolerant bacteria isolated from
marine polluted environments is due to their high biotechnological potential, and also
to the perspective of their application in different remediation technologies.  Using
enrichment  procedures,  two moderately  halophilic  Gram-negative  bacterial  strains
were isolated from seawater sample, which are tolerant to organic solvents. From their
experience  they  stated  that  the  cell  tolerance,  adhesion  and  cells  viability  of
Aeromonas  salmonicida IBBCt2  and  Pseudomonas  aeruginosa  IBBCt3  in  the
presence of organic solvents depends not only on its physicochemical properties and
its  concentration,  but  also  on  the  specific  response  of  the  cells,  and  the  cellular
response  is  not  the  same  for  those  bacterial  strains.  n-hexane,  n-heptane,
propylbenzene, with log POW between 3.69 and 4.39, were less toxic for Aeromonas
salmonicida IBBCt2 and Pseudomonas aeruginosa IBBCt3, compared with toluene,
styrene, xylene isomers and ethylbenzene, with log POW between 2.64 and 3.17. The
results indicated that  Aeromonas salmonicida IBBCt2 is more susceptible to organic
solvents than Pseudomonas aeruginosa IBBCt3. The mechanisms underlying solvent
tolerance (e.g., the existence of the efflux pumps) in Aeromonas salmonicida IBBCt2
and Pseudomonas aeruginosa IBBCt3 it was also studied.
Edward IA  et  al 2012  studied the petroleum contaminated  site  has  a  high
concentration  of  organic  solvents  and  heavy  metals.  Bacteria  surviving  in  the
contaminated site will implement efflux systems to evade from toxic organic solvents.
In  this  study,  an attempt  was taken  to  perceive the  relation between efflux pump
activity  and  organic  solvent  tolerance  of  bacteria.  B.  oleronius  isolated  from
petroleum contaminated site was utilized to investigate the role of efflux pump in
organic solvent tolerance.  The viability of cells  was significantly reduced in broth
supplemented  with  test  solvents  compared  to  untreated  bacteria.  Rhodamine  B
accumulation and efflux studies divulged that the bacterial isolate has greatly utilized
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the  efflux  pump  system  to  accumulate  and  siphon  out  the  dye.  The  intrinsic
correlation between solvent tolerance and efflux pumps was studied by treating the
bacterial  isolates  with  efflux  pump  inhibitors,  carbonyl  cyanide  m-
chlorophenylhydrazone (CCCP) and 2,4 Dintrophenol (DNP) in the  presence and
absence of organic solvents. Compared to the control, treated isolates have failed to
grow and showed different growth pattern indicating the critical role of efflux pumps
in solvent tolerance. Antimicrobials potentiation of solvent tolerance on B. oleronius
has showed significant changes in the growth pattern and presaged the activation of
efflux pump which in turn activated the solvent tolerance mechanisms. Their results
showed  that  bacteria  employ  a  wide  array  of  efflux  systems  to  tackle  the  high
concentration of solvents in the contaminated site.
Neetu Kumra Taneja et al 2007 developed simple, rapid, low-cost and robust
assays  for  screening  drugs  against  dormant  and  actively  growing  mycobacteria.
Actively growing aerobic and hypoxia-adapted dormant cultures of Mycobacterium
tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis were tested
for susceptibility to standard antimicrobial drugs by resazurin reduction assay. The
visual and fluorimetric MICs were compared with those obtained by the standard cfu
assay. Drug MICs for M. tuberculosis and M. bovis BCG were determined by the
aerobic resazurin microplate assay (REMA) and correlated well with those obtained
by  the  cfu  assay.  Metronidazole  and  nitrofurans  showed  comparable  bactericidal
activity in the hypoxic resazurin reduction assay (HyRRA). The HyRRA assay was
noted to be superior to the cfu assay in that it distinguished between metabolically
active dormant bacteria and non-viable organisms, unlike the cfu assay that could not
differentiate between these two populations. The HyRRA assay performed with good
concordance  in  both  fluorimetric  and  visual  formats  to  distinguish  between
bactericidal  and  bacteriostatic  effects  of  a  drug.  They  suggested  that  REMA and
HyRRA assays will be useful for anti-tubercular anti-dormancy compound screening
and  drug  susceptibility  testing  in  a  safe,  reliable,  easy and  cost-effective  manner
particularly in low resource countries. The application of the assays in M. smegmatis
or M. bovis BCG offers the distinct advantage of rapidly and safely screening anti-
tubercular compounds in a high-throughput format.
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Ashraf R and Shah NP2011 reported that intrinsic resistances to tetracycline,
vancomycin  and  erythromycin  are  common  in  Lactobacillus  species;  however,
resistance to streptomycin, clindamycin, gentamicin, oxacillin and lincosamide were
also reported in those species. Resistant markers tet(W), tet(M) and erm(B) have been
frequently detected in the resistant strains while van(A), lnu(A) and tet(L) have also
been found in some strains of Lactobacillus. Bifidobacteria are commonly resistant to
tetracycline,  streptomycin,  erythromycin,  gentamicin  and  clindamycin.  Resistance
genes van(A), tet(L) and tet(M) are often detected in Enterococcus. Reports suggest
enterococci to  transfer  tet(M)  to E.  faecalis  or  Listeria strains  and  van(A)  to
commercial  strain  of  Lactobacillus  acidophilus.  Streptococcus species  are  highly
resistant  to  tetracycline,  ciprofloxacin  and  aztreonam and  tet(M)  was  detected  in
strains  of  dairy origin.  Clinical  cases  of  endocarditis,  septicemia,  bacteremia and
septic  arthritis  due  to  the  species  of  Lactobacillus,  Saccharomyces,  Leuconostoc,
Pediococcus  and  Bifidobacterium  have  been  reported  in  patients  with  some
underlying medical conditions.
Nizami  Duran  et  al 2012  evaluated  the  association  between  the  antibiotic
susceptability patterns and the antibiotic resistance genes in staphylococcal isolates
obtained from various clinical  samples of patients attending a teaching hospital  in
Hatay, Turkey.
Mradula  Singh et  al 2009  studied the  drug resistant,  especially multi-drug
resistant (MDR) tuberculosis, fluoroquinolones (FQs) are used as second line drugs.
However,  the  incidence  of  FQ-resistant  Mycobacterium  tuberculosis  is  rapidly
increasing which may be due to extensive use of FQs in the treatment of various other
diseases. The most important known mechanism i.e., gyrA mutation in  FQ resistance
is not observed in a significant proportion of FQ resistant M. tuberculosis isolates
suggesting that the resistance may be because of other mechanisms such as an active
drug efflux pump. In this study we evaluated the role of the efflux pumps in quinolone
resistance  by  using  various  inhibitors  such  as  carbonyl  cyanide  m-chlorophenyl
hydrazone (CCCP), 2, 4-dinitrophenol (DNP) and verapamil, in clinical isolates of M.
tuberculosis
Janne  Kataja  and  Pentti  Huovinen  1998  studied  Streptococcus  pyogenes
isolates  (group  A streptococcus)  of  different   erythromycin  resistance  phenotypes
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were  collected  from  all  over  Finland  in  1994  and  1995  and  studied;  they  were
evaluated for their susceptibilities to 14 antimicrobial agents (396 isolates) and the
presence of different erythromycin resistance genes (45 isolates). The erythromycin-
resistant  isolates  with  the  macrolide-resistant  but  lincosamide-  and  streptogramin
Bsusceptible phenotype (M phenotype) were further studied for their plasmid contents
and the transferability of resistance genes. Resistance to antimicrobial agents other
than  macrolides,  clindamycin,  tetracycline,  and  chloramphenicol  was  not  found.
When compared to our previous study performed in 1990, the rate of resistance to
tetracycline increased from 10 to 93% among isolates with the inducible resistance
(IR) phenotype of macrolide, lincosamide, and streptogramin B (MLSB) resistance.
Tetracycline resistance was also found among 75% of the MLSB-resistant  isolates
with the constitutive resistance (CR) phenotype. Resistance to chloramphenicol was
found for the first  time in S.  pyogenes in Finland; 3% of the isolates with the IR
phenotype  were  resistant.  All  the  chloramphenicol-resistant  isolates  were  also
resistant to tetracycline. Detection of erythromycin resistance genes by PCR indicated
that,  with  the  exception  of  one  isolate  with  the  CR phenotype,  all  M-phenotype
isolates had the macrolide efflux (mefA) gene and all the MLSB-resistant isolates had
the  erythromycin  resistance  methylase  (ermTR)  gene;  the  isolate  with  the  CR
phenotype contained the ermB gene. No plasmid DNA could be isolated from the M-
phenotype isolates, but the mefA gene was transferred by conjugation.
Alasdair  P MacGowan et  al 2003  carried  out   the  antibacterial  effect  and
emergence  of  resistance  to  gemifloxacin  and  levofloxacin  in  an  in  vitro
pharmacokinetic  model  of  infection.  A panel  of  Streptococcus pneumoniae  strains
with known mechanisms of resistance were used; two strains had no known resistance
mechanism, two had efflux pumps, three had gyrA plus parC mutations, and one had
only a parC mutation. Gemifloxacin MICs were in the range of 0.016 to 0.25 mg/liter,
and  levofloxacin  MICs  ranged  from  1  to  16  mg/liter.  Antimicrobial  effect  was
measured  by  area  under  the  bacterial-kill  curve  up  to  72  h,  and  emergence  of
resistance  was  determined  by  population  analysis  profile  before  and  during  drug
exposure.  The  area  under  the  curve  (AUC)/MIC  ratios  for  gemifloxacin  and
levofloxacin were 35 to 544 and 3 to 48, respectively. As expected on the basis of
these  AUC/MIC  ratio  differences,  antibacterial  effect  was  much  greater  for
gemifloxacin  than  levofloxacin.  In  the  gemifloxacin  simulations,  mechanism  of
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resistance  as  well  as  MIC  determined  the  antibacterial  effect,  as  indicated  by
gemifloxacin’s greater effect against efflux strains compared to those with gyrA or
parC mutations despite similar MICs. This was not true of  levofloxacin. Emergence
of  resistance  was  not  easily  demonstrated  with  either  agent,  and  mechanism  of
resistance did not have any impact on it.
Thomas Schwartz 2002 viewed of the increasing interest in the possible role
played  by  hospital  and  municipal  wastewate  systems  in  the  selection  of
antibioticresistant  bacteria,  biofilms  were  investigated  using  enterococci,
staphylococci, Enterobacteriaceae, and heterotrophic bacteria as indicator organisms.
In addition to wastewater, biofilms were also investigated in drinking water from river
bank filtrate to estimate the occurrence of resistant bacteria and their resistance genes,
thus indicating possible transfer from wastewater and surface water to the drinking
water distribution network. Vancomycin-resistant enterococci were characterized by
antibiograms,  and  the  vanA resistance  gene  was  detected  by  molecular  biology
methods, including PCR. The vanA gene was found not only in wastewater biofilms
but also in drinking water biofilms in the absence of enterococci, indicating possible
gene  transfer  to  autochthonous  drinking  water  bacteria.  The  mecA gene encoding
methicillin resistance in staphylococci was detected in hospital wastewater biofilms
but not in any other compartment.  Enterobacterial ampC resistance genes encoding
L-lactamase activities were amplified by PCR from wastewater,  surface water and
drinking water biofilms
Gary S Gray1980 sequenced kanamycin resistance gene from Staphylococcus
aureus  and  its  structure  was  compared  with  similar  genes  isolated  from
Streptomycesfradiae and from two transposons, Tn5 and Tn903, originally isolated
from  Klebsiella pneumoniae  and  Salmonella typhirnurium,  respectively.  The genes
are  all  homologous  but,  since  their  common  ancestor,  have  undergone  extensive
divergence, with more than 43% divergence between the closest pair. The phylogeny
of the genes cannot be made congruent to the phylogeny of the taxa from which they
were  isolated  without  requiring  rather  improbable  differences  in  rates.  One  is
therefore led to conclude that there have been multiple occurrences of gene transfer
between  these  species.  Thus,  although  they  are  homologous,  they  are  neither
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orthologous nor paralogous. It was suggested that homologous genes of this type be
called xenologous.
Roberto Cabrera and Joaquím Ruiz 2004 studied the evolution of antimicrobial
resistance  in Salmonella isolates  causing  traveler's  diarrhea  (TD)  and  their
mechanisms of resistance to several antimicrobial agents were analyzed.
Anandi Martin et al 2003 worked on 150 Mycobacterium tuberculosis isolates
against  the second-line drugs ethionamide, kanamycin,  capreomycin,ofloxacin, and
para-aminosalicylic  acid  by  the  colorimetric  resazurin  microtiter  assay  and  the
proportionmethod. By visual reading, MICs were determined after 8 days and a very
good correlation between results by the colorimetric resazurin microtiter assay and the
proportion  method  were  reported.  The  colorimetric  resazurin  microtiter  assay  is
inexpensive, rapid, and simple to perform, and implementation of the assay is feasible
for low-resource countries.
Satyajit D.  Sarker et al 2007 modified the resazurin assay utilising microtitre-
plate, described by Drummond and Waigh in 2000, to achieve more accuracy in the
determination  of  the  minimum  inhibitory  concentration  (MIC)  values  of  natural
products, including crude extracts, chromatographic fractions or purified compounds
against various bacterial strains. This modified resazurin method is simple, sensitive,
rapid,  robust  and  reliable,  and  could  be  used  successfully  to  assess  antibacterial
properties of natural products.
Adel KK and Sabiha SS 2010 determined the site of antibiotic resistant genes
in Pseudomonas aeruginosa. 50 P Aeruginosa were isolated out of 250 samples from
hospitalized patients in different hospitals in Sulaymani city, Iraq, more over isolated
from soil  dustbin and sewage water.  The isolates were identified according to the
cultural, morphological  and biochemical tests, in addition to API 20E system. The
isolated  bacteria  were  screened  for  their  resistance  to  seventeen  commonly  used
antibiotics. The isolated P. aeruginosa show different pattern of antibiotic resistance,
they grouped in to 34 antibiotype. Organisms were 100% resist to (Amp, Cef, Er, Gm,
Lin, Pip and Cln), the lowest resistant recorded was 35% for Rif. Six  P. aeruginosa
isolates 12% revealed resistant to all seventeen used antibiotics, while nine isolates
18% were sensitive to one antibiotic, and 10 isolates were sensitive to two antibiotics,
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and remaining 50 isolates were sensitive to 3-5 antibiotics. Transformation process
appeared that the genes responsible for all tested antibiotics except Lin in P1 isolate,
and Lin and Tob in P8 isolate are located on plasmid DNA in isolated P. aeruginosa.
Kunihiko Nishino et al 2003 stated that histone-like protein H-NS is a major
component of the bacterial nucleoid and plays a crucial role in global gene regulation
of enteric bacteria. It is known that the expression of a variety of genes is repressed by
H-NS, and mutations in hns result in various phenotypes, but the role of H-NS in the
drug  resistance  of  Escherichia  coli  has  not  been  known.  Here  we  present  data
showing that H-NS contributes to multidrug resistance by regulating the expression of
multidrug exporter genes. Deletion of the hns gene from the _acrAB mutant increased
levels of resistance against antibiotics,  antiseptics, dyes,  and detergents.  Decreased
accumulation of ethidium bromide and rhodamine 6G in the hns mutant compared to
that in the parental strain was observed, suggesting the increased expression of some
drug exporter(s)  in this mutant.  The increased drug resistance and decreased drug
accumulation caused by the hns deletion were completely suppressed by deletion of
the multifunctional outer membrane channel gene tolC. At least eight drug exporter
systems require TolC for their functions. Among these, increased expression of acrEF,
mdtEF, and emrKY was observed in the hns strain by quantitative real-time reverse
transcription-PCR analysis.  The  hns-mediated  multidrug resistance  pattern is  quite
similar to that caused by overproduction of the AcrEF exporter. Deletion of the acrEF
gene greatly suppressed the level of hns-mediated multidrug resistance. However, this
strain still retained resistance to some compounds. The remainder of the multidrug
resistance  pattern  was  similar  to  that  conferred  by  overproduction  of  the  MdtEF
exporter. Double deletion of the mdtEF and acrEF genes completely suppressed hns-
mediated multidrug resistance,  indicating that hns-mediated multidrug resistance is
due to derepression of the acrEF and mdtEF drug exporter genes.
Olusegun O. Soge et al 2006 determined antibiotic resistance genes associated
with 17 Nigerian CTX-M-positiveKlebsiella pneumoniae plasmids from patients with
community-acquired  urinary  tract  infections  Methods:  The  size  and  restriction
patterns  of  the  plasmids  were  determined,  and  antibiotic  resistancegenes  were
identified  using  DNA–DNA  hybridization,  PCR  assays,  hybridization  of  PCR
products withinternal probes, and sequencing.
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Senka stated that 2007 since the discovery and subsequent widespread use of
antibiotics, a variety of bacterialspecies of human and animal origin have developed
numerousmechanisms that render bacteria resistant to some, and in certain cases to
nearly  all  antibiotics.  There  are  many  important  pathogens  that  are  resistant  to
multiple  antibiotic  classes,  and  infections  causedby  multidrug  resistant  (MDR)
organisms are limiting treatment options and compromising effective therapy. So the
emergence of antibiotic-resistant pathogens in bacterial populationsis a relevant field
of study in molecular and evolutionary biology, and in medical practice. There are two
main aspects to the biology of antimicrobial resistance. One is concerned with the
development,  acquisition and spread of the resistance gene itself.  The other is  the
specific biochemical mechanism conveyed by this resistance gene. In this review we
present some recent data on molecular mechanisms of antibiotic resistance
Laura  Paixao  etal,  2009  stated  that  the  Efflux  pump  activity  has  been
associated  with  multidrug  resistance  phenotypes  in  bacteria,  compromising  the
effectiveness  of  antimicrobial  therapy.  The  development  of  methods  for  the  early
detection and quantification of drug transport across the bacterial cell wall is a tool
essential to understand and overcome this type of drug resistance mechanism. This
approach was developed to study the transport of the efflux pump substrate ethidium
bromide (EtBr) across the cell envelope of  Escherichia coli  K-12 and derivatives,
differing in the expression of their efflux systems.
Desj  Simeoni  2007  stated  that  the  Staphylococci harbouring  antibiotic
resistance (AR) genes may represent a hazard for human health and, as other resistant
foodrelatedbacteria, they contribute to the spread of AR. In their study, they isolated
resistant  staphylococci  from an entire  swine production chain and investigated the
occurrence  of  11  genes  [aac(60)Ie-aph(200)Ia,  blaZ,  mecA,   andtet(K)]  encoding
resistance  to  some  antibiotics  largely  used  in  clinical  practice.  The  66  resistant
staphylococcal isolates were identified as  Staphylococcus epidermidis  (27 isolates),
Staphylococcus  aureus  (,  Staphylococcus  xylosus Staphylococcus  simulans
Staphylococcus pasteuri ,  Staphylococcus carnosus,  Staphylococcus lentus  isolates
and  Staphylococcus  sciuri  .  Specific-PCR  detection  of  AR  genes  showed  the
prevalence of the tet(K) gene in most of the isolates (89.4%), followed by tet(M) and
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ermC  (about  75%);  mecAwas  detected  in  more  than  half  of  S.  aureus  and  S.
epidermidis isolates. The genes vanA and vanB were not retrieved. It was found that a
high proportion of coagulase-positive and -negative isolates are multidrug-resistant
and some of  them carry up to  six  AR genes.  Their  findings  show that  the swine
production  chain  is  a  source  of  antibiotic-resistant  staphylococci  suggesting  the
importance of resistances urveillance in the food production environment.
Anja  S  Hummel  2007  studied  the  antibiotic  resistances  of  45  lactic  acid
bacteria  strains belonging to the genera Lactobacillus, Streptococcus,  Lactococcus,
Pediococcus, and Leuconostoc were investigated. Their objective was to determine
antibiotic resistances and to verify these at the genetic level, as is currently suggested
by  the  European  “qualified  presumption  of  safety”  safety  evaluation  system  for
industrial  starter strains.  In  addition,  they sought to pinpoint  possible problems in
resistance  determinations.  Primers  were  used  to  PCR  amplify  genes  involved
in_lactam antibiotic, chloramphenicol, tetracycline, and erythromycin resistance. The
presence  of  ribosomal  protection  protein  genes  and  the  ermB  gene  was  also
determined  by  using  a  gene  probe.  Generally,  the  incidences  of  erythromycin,
chloramphenicol, tetracycline, or _lactam resistances in the study were low (<7%). In
contrast, aminoglycoside (gentamicin and streptomycin) and ciprofloxacin resistances
were higher than 70%, indicating that these may constitute intrinsic resistances. The
genetic basis for ciprofloxacin resistance could not be verified, since no mutations
typical of quinolone resistances were detected in the quinolone determining regions of
the  par  C  and  gyrA  genes.  Some  starter  strains  showed  low-level  ampicillin,
penicillin,  chloramphenicol,  and  tetracycline  resistances,  but  no  known  resistance
genes could be detected. Although some strains possessed the cat gene, none of these
were phenotypically resistant to chloramphenicol. Using reverse transcription-PCR,
these  cat  genes  were  shown  to  be  silent  under  both  inducing  and  non  inducing
conditions. Only Lactobacillus salivarius BFE 7441 possessed an ermB gene, which
was encoded on the chromosome and which could not be transferred in filter-mating
experiments. Their  study clearly demonstrates problems encountered with resistance
testing, in that the break point values are often in adequately identified,  resistance
genes  may be  present  but  silent,  and  the  genetic  basis  and  associated  resistance
mechanisms towardsome antibiotics are still unknown. 
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Neal C. stewart 1996 stated the somatic embryos of Jack, a Glycine max (1.)
Merrill  cultivar,  were  transformed  using  microprojectile  bombardment  with  a
synthetic Bacillus thuringiensis insecticidal crystal protein gene (BtcrylAc) driven by
the 35s promoter and linked to the HPH gene. Approximately 10 g of tissue was
bombarded, and three transgeniclines were selected on hygromycin-containing media
and convertedinto plants. The recovered lines contained the HPHgene, but the Btgene
was lost in one line. The plasmid was rearranged in the secondline, and the third line
had two copies, one of which was rearranged.The CrylAc protein accumulated up to
46 ng mg-’ extractableprotein. In detached-leaf bioassays, plants with an intact copy
of the Bt gene, and to a lesser extent those with the rearranged copy, were protected
from damage from corn ear worm  (Helicoverpazea), soybean looper  (Pseudoplusia
includens), tobacco  budworm  (Heliothis  virescens),  and  velvetbean  caterpillar
(Anticarsiagemmatalis).  Corn  earworm  produced  less  than  3%  defoliation
ontransgenic plants, compared with 20% on the lepidopteran-resistant breeding line
CatlR 81-296, and more than 40% on susceptible cultivars. Unlike previous reports of
soybean transformation using this technique, all plants were fertile. 
Notani. n. k.  et al 1984  studied and reported that certain species of bacteria
can become competent to take up high molecular weight DNA from the surrounding
medium. DNA homologous to resident chromosomal DNA istransported, processed
and recombined with the resident DNA. There are some variations insteps leading to
transformation  between  Gram-positive  bacteria  like  biplococcus  pneumonia  and
Gram-negative bacteria represented by Haemophilus influenzae but the integration is
bysingle-strand displacement in both cases. Plasmid (RSF0885)transformation is low
in  Haemophilus  influenzae but  this  is  increased  significantly  if  (homologous)
chromosomal  DNAis  spliced  to  plasmid  DNA.  In  Haemophilus  influenzae,  rec1
function  is  required  for  peak  transformation  with  chimeric  plasmids.  Chimeric
plasmid  fixed  presumably  extrachromosomally  undergoes  frequent  recombination
between homologous segments contained in resident chromosome and the plasmid.
Niimi  K.   et  al 2005  the  Micafungin  and  caspofungin  susceptibilities  of
Candida albicans laboratory and clinical  isolates  and of  Saccharomyces cerevisiae
strains stably hyperexpressing fungal ATP-binding cassette (ABC) or major facilitator
superfamily (MFS) transporters involved in azole resistance were determined using
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three separate methods.by (Niimi K).  yeast strains hyperexpressing individual alleles
of  ABC  transporters  or  an  MFS  transporter  from  C.  albicans  gave  the  expected
resistance  profiles  for  the  azoles  fluconazole,itraconazole,  and  voriconazole.  The
strain  shyperexpressing  CDR2  showed  slightly  decreased  susceptibility  to
caspofungin in agar plate drug resistance assays, as previously reported, but increased
susceptibility to micafungin compared with either the strains hyperexpressing CDR1
or the null  parent deleted of  seven ABC transporters.  The strains hyperexpressing
CDR1 showed slightly decreased susceptibility to micafungin in these assays.  A C.
albicans clinical isolate overexpressing both Cdr1p and Cdr2p relative to its azole-
sensitive isogenic progenitor acquired resistance toazole drugs and showed reduced
susceptibility  to  caspofungin  and  slightly  increased  susceptibility  to  micafunginin
agar plate drug resistance assays. None of the strains showed significant resistance to
micafungin orcaspofungin in liquid microdilution susceptibility assays. The antifungal
activities  of  micafungin  and  caspofunginwere  similar  in  agarose  diffusion  assays,
although  the  shape  and  size  of  the  caspofungin  inhibitory zoneswere  affected  by
medium  composition.  The  assessment  of  micafungin  and  caspofungin  potency  is
therefore assay dependent; the differences seen with agar plate drug resistance assays
occur  over  narrow  ranges  of  echinocandin  concentrations  and  are  not  of  clinical
significance.
Aure lie A. Huet 2008 stated the Biocides and dyes are commonly employed
in hospital and laboratory settings. Many of these agents are substrates for multiple-
drug resistance (MDR)-conferring efflux pumps of both Gram-positive and Gram-
negative  organisms.  Several  such  pumps  have  been  identified  in  Staphylococcus
aureus,  and mutants over  expressing the NorA and MepA MDR pumps following
exposure  to  fluoroquinolones  have  been identified.  The effect  of  exposure to  low
concentrations of biocides and dyes on the expression of specific pump genes has not
been evaluated. Using quantitative reverse-transcription PCR we found that exposure
of clinical isolates to low concentrations of a variety of biocides and dyes in a single
step,  or  to  gradually  increasing  concentrations  over  several  days,  resulted  in  the
appearance of mutants over expressing mepA, mdeA, norA and norC, with mepA over
expression predominating. Over expression was frequently associated with promoter-
region or regulatory protein mutations. Mutants having significant increases in MICs
of common pump substrates but no changes in expression of studied pump genes were
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also observed; in these cases changes in expression of as-yet-unidentified MDR pump
genes  may  have  occurred.  Strains  of  S.  aureus  that  exist  in  relatively  protected
environments and are repeatedly exposed to sublethal concentrations of biocides can
develop efflux-related resistance to those agents, and acquisition of such strains poses
a threat to patients treated with antimicrobial agents that are also substrates for those
pumps, such as ciprofloxacin and moxifloxacin.
Mahipal  Singh  et  al 2010  optimized  various  parameters  of  standard
CaCl2/heat shock method on transformation of  Escherichia coli  strain DH5α -T1R
with plasmid pUC19.  Of  the four  different  heat  shock temperatures  (32°C,  37°C,
42°C  and  47°C)  studied,  42°C  treatment  exhibited  maximum  efficiency  of
transformation  as  revealed  by ampicillin-resistant  colonies  appearing  on  LB Agar
ampicillin plates. Of the five different heat shock exposure times, a pulse of 30 second
duration combined with 42°C heat shock temperature exhibited maximum efficiency.
It was observed that although transformation of CaCl2 treated cells occurs even before
heat shock treatment, the efficiency was ~15 fold higher after heat shock. When the
cells were further incubated on ice (after heatshock) for 10 min, the transformation
efficiency increased by 24 fold compared to no heat shock and 1.6 fold compared to
heat  shock treatment.  There was a marginal  decrease in transformation when cells
were incubated at  room temperature instead of  ice after  heat  shock. These results
suggest that a heat shock pulse of 30 sec at 42°C followed by a 10 min ice incubation
step are ideal parameters to obtain maximum transformation efficiency in DH5α -T1R
strain.  Results  also  suggest  that  post  heat  shock  cold  incubation  step  is  also  an
important factor and enhances transformation of E. coli significantly
Ameena S. M. Jum studied a five hundred stool samples were collected from
patients with diarrhea (infants and childrenunder ten years of age) admitted to the
Pediatric and Maternity Hospital in Erbil City from March 2007 to September 2007.
The samples were cultured on different culture media and according to the colony
morphology, biochemical reactions and by the use of API 20E system, 35 (7%) were
diagnosed as E.coli I, 8 (1.6%) E.coli II, 17 (3.4%) E.coli III, 22 (4.4%) E.coli IV, 8
(1.6%)  Shigella dysenteriae,  16 (3.2%)  Salmonella arizonae, 12(2.4%)  Salmonella
typhi and 6 (1.2%) Vibrio cholerae. In addition, cases of  Entamoeba histolytica 175
(35%),Giardia lamblia 102 (20.4%) and Hymenolepis nana 2 (2.4%) were identified.
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No infectious agents were found in 75 (15%) of the samples. 22 (4.4%) of the samples
had mixed infections. The sensitivity of E.coli O157:H7isolate to different antibiotics
was performed.  There was a variation in the resistance ranging from 8.5-90%.the
determination of the site of genes responsible for the antibiotic resistance in  E.coli
O157:H7 was performed using the genetic transformation method for  E.coli DH5α
laboratory strain with the DNA that is absent from the highly resistant strains, E.coli
O157:H7 4 and E. coli O157:H7 6. The transformation process succeeded when using
the plasmid DNA for strain 4 and failed when using strain 6. It was evident that the
genes  responsible  for  resistance  to  the  following  antibiotics  were  located  on  the
plasmid DNA: amoxicillin, amoxiclav, ampicillin, cephalexine, cefixime, cefotaxime,
doxycyclin, gentamycin, nalidixic acid, nitrofurantoin, rifampicin, streptomycin and
tetracycline.  Whereas  the  genes  responsible  for  the  following antibiotic  resistance
were  located  on  the  chromosome:  amikacin,  erythromycin,  chloramphenicol,
ciprofloxacin, tobramycin and trimethoprim.
Douglas Hanahan  et al 1983 stated the factors that affect the probability of
genetic transformation of Escherichia coli by plasmids have been evaluated. A set of
conditions  is  described  under  which  about  one  in  every  400  plasmid  molecules
produces  a  transformed  cell.  These  conditions  include  cell  growth  in  medium
containing elevated levels of Mg 2+. and incubation of the cells at 0~ in a solution of
Mn 2+, ("a 2+, Rb + or K +, dimethyl sulfoxide, dithiothreitol, and hexamine cobalt
(III).  Transibrmation  efficiency  declines  linearly  with  increasing  plasmid  size.
Relaxed  and  supercoiled  plasmids  transformation  with  similar  probabilities.  Non-
transforming  DNAs  compete  consistent  with  mass.  No  significant  variation  is
observed between competing DNAs of different source, complexity, length or form.
Competition with both transforming and  non transforming plasmids  indicates  that
each cell is capable of taking up many DNA molecules, and that the establishment of
a transformation event is neither helped nor hindered significantly by the presence of
multiple plasmids.
Sharon D. Cosloy and Michio Oishi 1972 studied the an auxotrophic strain of
E. coli K12 treatedwith CaCl2 was transformed for several markers at a frequency of
up to 6 per recipient cell by a DNA preparation isolated from a prototrophic strain.
The transforming activity of the DNA preparation was eliminated by treatment with
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DNase, heat, or sonication, whereas RNse or Pronase treatment had little effect. Two
closely  linked  genetic  markers  (leu  and  ara)  showed  a  high  degree  of  co
transformation linkage when high molecular weight DNA was used, but the linkage
was almost completely eliminated when sheared, smaller molecular weight DNA was
used. There is genetic evidence that the transformation is a result of the replacement
of the preexisting genetic marker on the chromosome by that of the donor DNA.
Glenn W. Kaatz 2000 et al created the Staphylococcus aureus norA disruption
mutant by allelic replacement. Exposure of this mutan to norfloxacin produced SA
K1748, a derivative with raised fluoroquinolone MICs, found to be the result of agrlA
mutation,  and  raised  organic  cation  MICs.  Ethidium  and  enoxacin  uptake  was
identical  in  SA K1748 and  its  parent,  but  pre-exposure  of  SA K1748 to  organic
cations caused a reduction in ethidium uptake as a result of increased efflux. Altered
ethidium uptake  and  efflux,  as  well  as  increased  MICs  of  other  organic  cations,
suggest  that  SA K1748 possesses  a  non-NorA multidrug efflux  transporter  that  is
inducible by its substrates. Factors that affect the probability of genetic transformation
Hiroshi Nikaido 2009 studied the large amounts of antibiotics used for human
therapy, as well as for farm animals and even for fishin aquaculture, resulted in the
selection of  pathogenic bacteria  resistant  to  multiple  drugs.  Multidrugresistance  in
bacteria  may be  generated  by one  of  two  mechanisms.  First,  these  bacteria  may
accumulate multiple genes, each coding for resistance to a single drug, within a single
cell.  This  accumulation  occurs  typically  on  resistance  (R)  plasmids.  Second,
multidrug resistance may also occur by the increased expression of genes that code
for multidrug efflux pumps, extruding a widerange of drugs. 
Magdalena Chroma 2010 reviewed and reported the emergence of antibiotic
resistance. currently, bacterial resistance to antibiotics poses a major problem in both
hospital and community settings throughout the world.
David Dubnau 1999 stated that the natural competence is widespread among
bacterial species. The mechanism of DNA uptake in both gram-positive and gram-
negative  bacteria  was  also  reviewed.  By  their  Uptake  of  DNA across  the  inner
membrane is probably similar in gram positive and gram-negative bacteria,  and at
23
least  some of  the required proteins  are  orthologs.  The initial  transformation  steps
differ, as expected, from the presence of an outer membrane only in the gram-negative
organisms. The similarity of certain essential competence proteins to those required
for the assembly of type-4 pili and fortype-2 protein secretion is discussed. Finally
several  hypotheses  for  the  biological  role  of  transformation  are  presented  and
evaluated by their.
 Simeon Oloni Kotchoni 2003 developed a rapid protocol for plasmid DNA
extraction based on the alkaline lysis method of plasmid preparation (extraction at pH
8.0).  Instead  old  method which  is  a  five  coming using this  new method,  a  good
plasmid  preparation  can  be  made  in  approximately  one  hour.  The  plasmids  are
suitable for any subsequent molecular applications in the laboratory. By applying the
recommendations  to avoid contaminations and to maximize the plasmid yield and
quality during extraction, their protocol could be a valuable reference especially when
analyzing a large number of samples.
Thomas  P Quinn  and  Katrina  T  Trevor  1997  Isolation  of  low-molecular-
weight DNA from eukaryotic cells entails the separation of a very small quantity of
plasmid DNA from a much larger quantity of genomic DNA. Traditionally, the Hirt
extraction method (3) has been used for this purpose. This method, however, is labor-
intensive,  involving  extensive  precipitations  andphenol/chloroform  extractions.  In
their report,  three alternative methods are compared for the isolation of episomalc
DNA expression vectors  containing the human interleukin-2 (IL-2)  or  interferon-g
(IFN-g) gene from T lymphocytesthat were stably transfected with the corresponding
constructs: (i)a boilingmethod (4), (ii)alkaline lysis basedon the method of Birnboim
and  Doly(1)  in  combination  with  a  phenol/chloroform  extraction  and  ethanol
precipitationand (iii)the QIAprepÒ procedure (Qiagen, Chatsworth, CA, USA), which
combines alkaline lysis of the samples with an adsorption of plasmid DNAonto a
silica matrix. All procedures were originally designed for plasmid preparations from
Escherichia coli
Amin  et  al 2009   reported  the  antibiotic  resistance  pattern  and  extended
spectrum β-lactamase production is cultures of forty  Klebsiella pneumoniae  isolates
isolated  in  a  Tertiary  Care  Hospital  in  Islamabad  Pakistan  towards  novel
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cephalosporin  (first,  second  and  third  generation),  floroquinolones,  carbapenems,
amoxicillin/clavulanic acid and lincomycin by disc sensitivity,  minimum inhibitory
concentration (MIC) and minimum bactericidal concentration (MBC). Cephalosporin
was reported as highly resistant (cephradine 100%, cephalexin 75%, cefeclor 87.5%,
ceftriaxone 85%,  cefotaxime 82.5%),  lincomycin  (100%),  followed  by quinolones
(ciprofloxacin  55%,  ofloxacin  47.5%,  nalidixic  acid  42.5%,  norfloxacin
35%,moxifloxacin 25%, gatifloxacin 15%),  amoxicillin/clavulanic acid 12.5%, and
carbapenams (imipenem, meropenem) with the least resistance at 7.5%. About 47.5%
strains were found to  be ESBLs positive among which 15.8% of the strains were
producing carbapenamase, 26.5% with inducible cephalosporinase of bush functional
gene 2e. No inhibitor resistant TEM-β lactamases (IRT) positive strains were found.
High antibiotic resistance rate against commonly use dantibiotics is a disadvantage for
health  care  system  in  countries  like  Pakistan  as  it  can  greatly  effect  patient
management.  Therefore  they  recommend  physicians  must  change  prescription
priorities towards alternative antibiotics to reduce the burden of antibiotics resistance.
Lateef.A et al2003  studied the resistance pattern and mechanisms of bacterial
isolates obtained from clinical origin, soil, industrial effluent, orange juice products
and drinking water were studied using commonly used antibiotics. The microbial load
of  the  water  samples,  industrial  effluent  and  orange juice  products  were  1.0×10–
2.25×10, 2.15×10, and 3.5×104.15×10 cfu mL, respectively. The faecal coliform test
revealed that only two out of twenty orange juice products had MPN of 2 and20, the
MPN of water ranged from 1800, while the effluent had MPN of ≥1800. The bacterial
isolates that were isolated include  E. coli,  S. aureus,  P. vulgaris,  S. marcescens,  S.
pyogenes,  B.cereus,  B. subtilis,  Micrococcus  sp.,  Klebsiella  sp.,  P. aeruginosa,  and
Enterobacter  sp.  Also, clinical  and soil  isolates of  P. aeruginosa  were used in the
study.  Among  the  eight  antibiotics  tested  for  resistance  on  five  strains  of  each
bacterium,  seven  different  resistance  patterns  were  observed  among  the  bacterial
isolates obtained from water, effluent and orange juice products. Among the clinical
and  soil  isolates  of  P.  aeruginosa,  four  multiple-drug  resistance  patterns  were
obtained.  Thirty  strains  of  E.  coli  and  S.  aureus  were  tested  for  β-lactamase
production and fourteen strains, seven each of  E. coli  and  S. aureus  that had high
Minimum  Inhibitory  Concentration  values  (MIC)  for  both  Amoxycillin  and
Cloxacillin were positive.
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Asma Bashir et al (2007) stated that although most a bacterial infections of the
skin bear out to be minor in nature, a few such dermatologic entities are major, to the
spot of yet being fatal. The mortality rate is usually up to 30% to 50% and depends
upon the type of infection, original disease, and resistant type. In this study hundred
and five bacterial strains were isolated from skin wounds, burns and acne patients
from  hospitals  at  different  locations  in  the  cosmopolitan  city  of  Karachi.  These
bacterial strains were identified by conventional methods. Seventy two percent (72%)
of  total  isolated  organisms  were  found  to  be  Staphylococcus  aureus  while  the
remaining thirty three percent (33%) were Staphylococcus epidermidis. The antibiotic
resistance  of  identified  organisms  was  carried  out  by  disc-diffusion  method  with
commercially available disc of five antibiotics having different mode of actions such
as  cell  wall  synthesis  inhibitors,  membrane  permeability  alternatives  and  DNA
synthesis inhibitors. Staphylococcus aureusshow more resistant to these antibiotics as
compared  to  Staphylococcus  epidermidis.  The  most  effective  antibiotic  for
Staphylococcus aureus is vancomycin showing 80.5% efficacy, then methicillin with
68.0% efficacy, erythromycin with 55.6% efficacy, novobiocin with 54.1% efficacy
and  then  bacitracin  with  25.0%  efficacy.  The  most  effective  antibiotic  for
Staphylococcus epidermidis  is methicillin showing 84.8% efficacy,then vancomycin
with  81.2%  efficacy,  novobiocin  with  63.6%  efficacy,  erythromycin  with  42.4%
efficacy and then bacitracin with 27.8% efficacy.
Melanie  P Dautle  et  al 2004  performed  in  vitro  analysis  of  7  antibiotics
against100  clinical  bacterial  isolates  enriched  from  pediatric  gastrostomy  tubes.
Various  gram  positive  and  negative  organisms  were  purified  from  percutaneous
pediatric feeding tubes and assayed for antibiotic susceptibility and resistance. A total
of10  gram-negative  isolates,  Predominantl  Escherichia  coli,  and  90  gram-positive
organisms, mostly belonging to the  Staphylococcus  and  Enterococcus  genuses were
examined  for  antimicrobial  resistance  and  sensitivity.  Seven  antibiotics,  which
included ampicillin, cefazolin, ceftriaxone, ciprofloxacin, gentamicin, oxacillin, and
vancomycin,  were tested based on their  possible usein pediatric  patients requiring
feeding  tubes  for  nutritional  support.  Minim  inhibitory  concentrations  were
determined for all isolates and their relative resistance profiles were generated. The
Staphylococcus  genus possessed the highest diversity for antibiotic resistance while
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organisms comprising the Enterococcus genus exhibited marginal levels of resistance
to  the  antibiotics  tested  in  this  study.  Approximatel43%  of  the  isolates  tested
displayed  multiple  drug resistance,  with the predominant  species belonging to the
Staphylococcus  genus.  This  investigation reports  the  effectiveness  of  7  commonly
used  antibiotics  on  various  microbial  species  that  are  capable  of  initiating  and
maintaining bacterial biofilms on surgically implanted feeding tubes.
Mustafa Oskay et  al  2009 reported the plants used for traditional medicine
contain a  wide range  of  substances  which  can  be used to  treat  various  infectious
diseases. Hence, antibacterial activities of ethanolic extract of 19 plant species were
studied against multi-drug resistant clinical isolates using agar well diffusion method.
Extracts of Liquidambar oriental is, Vitisvinifera, Punica granatum, Cornus sanguinea,
Euphorbia peplus,  Ecballium elaterium,  Inula viscose and  Liquidambar oriental  is
showed broad-spectrum antibacterial activity with inhibition zones ranging from 8 to
26 mm. The most  resistant  organisms were  Escherichia coli  (E.coli)  (Ampicillin-,
amoxycillin-  and  sulfamethoxazole-resistant),  Stenotrophomonas  Maltophilia
(S.maltophilia) (Amoxycillin- and nalidixic acid-resistant) and Klebsiella pneumoniae
(K.pneumoniae)  (Ampicillin-,  amoxycillin-  and  aztreonam-resistant),  and  the  most
susceptiblespecies  were  Staphylococcus  aureus  (S.  aureus)  (Penicillin  G-  and
oxacillin-resistant),  Streptococcus  pyogenes  (S.  pyogenes)  (Penicillin  G-,
erythromycin-  and  clindamycin-resistant)  and  Pseudomonas  aeruginosa  (P.
aeruginosa)  (Sulfamethoxazole-  and  novobiocin-resistant),  respectively.  Minimum
Inhibitory  Concentrations  (MIC)  of  crude  extracts  were  determined  forthe  seven
highly  active  plants  showing  activity  against  methicillin  resistant  S.  aureus
(MRSA),E.  coli,  P. aeruginosa,  S.  pneumoniae and the reference bacteria  (E.  coli
ATCC 11229 and Kocuria rhizophila ATCC 9341 NA). MICs of active extracts ranged
from 8 to 14.2 mg/mL against one or other test bacteria.
Adenike A. O. Ogunshe 2006 studied the massive problems facing the primary
health  care  system  in  Nigeria,  the  consumer  preference  for  indigenous  herbal
medications is  on the increase.  Since it  is  possibility that  herbal  medications may
harbour  pathogenic  bacteria  of  clinical  significance,  the  study  determined  the
phenotypic antibiotic pattern of associated bacterial isolates using modified agar disc-
diffusion and  agar  well-diffusion methods.  All  isolated bacterial  species  exhibited
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mono and/or multiple  in vitro  phenotypic antibiotic resistance to the test antibiotic
(discs).  High  resistance  patterns  were  also  observed  towards  paediatric  antibiotic
suspensions.  This  study  confirmed  that  most  indigenous  orally  consumed  herbal
medications  in  Nigeria  harbour  bacterial  flora  that  exhibit  multiple  resistance  to
routinely used antibiotics.
Srisurang Tantimavanich 2002 stated the streptococci that were dependent for
their growth upon staphylococci were isolated from a patient with sub-acute bacterial
endocarditis and subsequently identified as nutritionally variant  streptococci (NVS).
Failure  of  the  isolate  to  grow  on  agar  media  supplemented  with  pyridoxal
hydrochloride or L-cysteine,  the known supporting growth factors for  NVS, made
conventional antimicrobial disc diffusion assay impossible. We modified the assay by
co-inoculating Staphylococcus aureus resistant to the drugs being tested as a helper to
support the growth of the NVS. Streaking S. aureus closely to the antibiotic discs that
were  placed  above NVS resulted  in  the  growth  of  satellite  colonies  of  NVS that
orbited  the  S.  aureus  and  that  produced  a  pattern  of  interrupted  zones  of  growth
inhibition. Using an alternative method – adding staphylococcal secreting factor(s) to
a 10% staphylococcal cell-free culture supernatant and adding this to an antibiotic
susceptibility testing medium, – we found that the NVS formed colonies that formed
clear  zones  of  growth  inhibition  around  the  disc.  When  the  sizes  of  the  growth
inhibition  zones  produced  by  both  these  methods  were  compared  with  those
recommened by the NCCLS, the NVS were found to be susceptible to penicillin,
vancomycin,  erythromycin,  chloramphenicol,  cefoperazone,  cefamandole  and
ofloxacin and resistant to co-trimoxazole, gentamicin and tetracycline. Based on the
findings,  vancomycin  was  selected  for  treatment  and  the  patient  was  cured  of
endocarditis. The correlation between the in vitro drug susceptibility testing and the in
vivo  clinical response indicated that the modified antibiotic susceptibility test is an
appropriate method for establishing antibiotic regimens significantly by the presence
of multiple plasmid 
           Gulcan ozbakir et al 2010 studied the E. coli strains, isolated from different
clinical materials, were analysed according to their antibiotic resistance patterns and
plasmid DNA profiles. When the incidence of E. coli infections are considered, more
E. coli  infections were observed in females than in males. Of the all  E. coli  strains
isolated from clinical materials, 27% were resistant to only one antibiotic, 25% were
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resistant to 6 antibiotics and resistance to all 8 antibiotics was established as 6%. In
addition to these, resistance rate was highest for ampicillin and ciprofloxacin, whereas
lowest  resistance  was  displayed  against  Piperacillin/Tazobactam.  According  to  the
antibiotic  resistance  patterns  of  E.  coli  strains,  10  different  antibiotypes  were
generated and the one, which was observed in highest frequency includes ampicillin–
resistant property in itself (antibiotype 1). When the plasmid profiles of E. coli strains
are  examined,  the  profile  which  includes  single  band  was  observed  as  the  most
frequent  one.  It  was also established that  most of  the  E. coli  strains,  which were
classified in that plasmid profile, acquire the properties of antibiotype 1. Besides it
was also observed that; some of the E. coli strains, which do not contain any plasmid
in their cells showed resistance to various antibiotics.
               Hleba L, Kacaniova.M, et al 2011,statet the   antibiotic resistance was
investigated in 67 samples of  Enterobacteriaceae  genera isolates from milk, cheese
and other dairy products in this work. The samples were obtained from conventional
farms  in  Slovakia.  Four  samples  of  isolates  were  positive  for  Salmonella  spp.,
Salmonella enterica ser. typhimurium and enteritidis. A great proportion of resistant
strain  from  Enterobacteriaceae  genera  was  found.  There  was  detected  a  high
resistance in milk samples to ampicillin (57.14%), to streptomycin and tetracycline
(14.28%),  to  chloramphenicol  (9.52%).  Bacteria  from  the  cheese  samples  were
resistant to ampicillin (84.0%), to tetracycline (24.0%). In the samples of other dairy
products was found resistance to ampicillin (66.66%), to tetracycline (52.38%) and to
streptomycin  (14.28%).  Among  all  samples  observed,  it  was  found  resistance  to
ampicillin  (69.26%),  tetracycline  (30.22%),  streptomycin  (9.52%)  and  to
chloramphenicol (3.17%). Resistance to other antibiotics was not detected. From all
observed samples we detected Salmonella spp. in 5.97 %, Salmonella spp. was found
in dairy samples in 19.04 %. Antibiotic resistance was investigated in 13 colonies of
Salmonella  spp.  as  well.  The  highest  resistance  was  to  tetracycline  (30.76  %),
ampicillin and tigecycline (23.07 %), to piperacillin (15.38 %) and chloramphenicol
(7.69 %). Resistance to the other monitored antibiotics was not detected. High number
of antibiotic
           
          Keith Poole 2001 studied Pseudomonas aeruginosa is an opportunistic human
pathogen characterized by an innate resistance to multiple  antimicrobial  agents.  A
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major contribution to this intrinsic multidrug resistance is provided by a number of
broadly-specific  multidrug  efflux  systems,  including  MexAB-OprM  and  MexXY-
OprM. In addition, these and two additional tripartite efflux systems, MexCD-OprJ
and MexEF-OprN, promote acquired multidrug resistance as a result of mutational
hyperexpression of the efflux genes. In addition to antibiotics, these pumps promote
export of numerous dyes,  detergents, inhibitors, disinfectants, organic solvents and
homoserine lactones involved in quorum sensing. The efflux pump proteins are highly
homologous and consist of a cytoplasmic membraneassociated drug-proton antiporter
of the Resistance - Nodulation-Division (RND) family, an outer membrane channel-
forming protein [sometimes called outer membrane factor (OMF)] and a periplasmic
membrane fusion protein (MFP). Homologues of these systems have been described
in Stenotrophomonas maltophilia, Burkholderia cepacia, Burkholderia pseudomallei
and the non-pathogen Pseudomonas putida, where they play a role in export of and
resistance  to  multiple  antimicrobial  agents  and/or  organic  solvents.  Although  the
natural  function  of  these  multidrug  efflux  systems  is  largely  unknown,  their
contribution to antibiotic resistance and their conservation in a number of important
human pathogens makes them logical targets for therapeutic intervention.
             Didier Hocquet 2007 stated investigated the resistance mechanisms to
lactams,  aminoglycosides,  and  fluoroquinolones  of  120  bacteremic  strains  of
Pseudomonas aeruginosa. Pulsed-field gel electrophoresis genotyping showed that 97
of these strains were represented by a single isolate,  10 by 2 and 1 by 3 clonally
related isolates, respectively. Seventy-five percent (90 out of 120) of the bacteremic P.
aeruginosa  strains  displayed  a  significant  resistance  to  one  or  more  of  the tested
antimicrobials (up to  11 for  1 strain).  These strains  were found to  harbor a great
diversity of resistance mechanisms (up to 7 in 1 strain), leading to various levels of
drug resistance. Interestingly, 11 and 36% of the isolates appeared to overproduce the
MexAB-OprM and MexXY-OprM efflux systems, respectively. Altogether, our results
show  that  P.  aeruginosa  may  accumulate  intrinsic  (overproduction  of
cephalosporinase AmpC, increased drug efflux, fluoroquinolone target mutations, and
deficient  production  of  porin  OprD)  and  exogenous  (production  of  secondary
lactamases and aminoglycoside- modifying enzymes) resistance mechanisms without
losing its ability to generate severe bloodstream infections. Consequently, clinicians
should be aware that multidrug-resistant P. aeruginosa may remain fully pathogenic
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          Tanya  Strateva  And  Daniel  Yordanov  2009,  Pseudomonas  aeruginosa
nosocomial Nosocomial  infections caused by this organism are often hard to treat
because of both the intrinsic resistance of the species (it has constitutive expression of
AmpC b-lactamase and efflux pumps, combined with a low permeability of the outer
membrane),  and its  remarkable ability to acquire further resistance mechanisms to
multiple  groups of antimicrobial  agents,  including b-lactams, aminoglycosides and
fluoroquinolones. P.  eruginosa represents a phenomenon of bacterial resistance, since
practically  all  known  mechanisms  of  antimicrobial  resistance  can  be  seen  in  it:
derepression  of  chromosomal  AmpC  cephalosporinase;  production  of  plasmid  or
integronmediated  b-lactamases  from different  molecular  classes   (carbenicillinases
and extendedspectrum b-lactamases belonging to class A, class D oxacillinases and
class B carbapenemhydrolysing enzymes); diminished outer membrane permeability
(loss of OprD proteins); overexpression of active efflux systems with wide substrate
profiles;  synthesis  of  aminoglycosidemodifying  enzymes  (phosphoryltransferases,
acetyltransferases  and  adenylyltransferases);  and  structural  alterations  of
topoisomerases  II  and  IV  determining  quinolone  resistance.  Worryingly,  these
mechanisms  are  often  present  simultaneously,  thereby  conferring  multiresistant
phenotypes. This review describes the known resistance mechanisms in P. aeruginosa
to  the  most  frequently  administrated  antipseudomonal  antibiotics:  b-lactams,
aminoglycosides and fluoroquinolones
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3. AIM OF WORK
• To understand the microbial resistance towards the selected antibiotics.
• To determine the ability of microbes to transfer resistance characters.
• To isolate plasmid and determine the molecular weight.
• To  understand  the  mechanism  (efflux  pump)  of  the  clinical  isolates  to  resist
antibiotic.
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4. PLAN OF WORK
Collection  of  clinical  bacterial  isolates  and
antibiotics
↓
Determination  of  MIC  and  Susceptibility
analysis
↓
Isolation  of  plasmid  DNA  from  resistant
bacteria
↓
Agarose Gel Electrophoresis
↓
Transformation assay
↓
Efflux pump analysis
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5. Material and methods
5.1. Table 1 List of Chemicals & Media
S.No Chemical Company
1 Ampicillin disc Himedia
2 Chloromphenicol disc Hi media
3 Roxithromycin disc Himedia
4 Ceftriaxone disc Himedia
5 Nutrient broth Himedia
6 Nutrient agar Himedia
7 Muller hinton agar Himedia
8 Resazurin dye Himedia
9 Ethidium bromide SRL
10 Calcium chloride Ottokemi
11 Glucose Nice Chem
12 Isopropanol Finar
5.2. Table 2 Strains 
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S.No Culture Obtained from laboratory
1 Pseudomonas aeruginosa Vijay laboratory
2 Staphloccocus aeurus Vijay laboratory
5.3. Table 3 List of Instrument Used
S.No Instruments Manufacture
1 Incubator rotary shaker Scigenics Orbitek
2 Incubator ILTS
3 Centrifuge Remi R24
4 Autoclave Equitron
5 Pipette Qualigens 
6 Beaker Qualigens 
7 Hot air oven Ausco
8 Centrifuge tubes Tarsons
9 Measuring cylinder Qualigens 
10. pH meter Shimadzu
11. Erlenmeyer flask Qualigens
12. Digital balance Shimadzu AY220
13. Colorimeter Aimil ltd
14. Water bath ITC
15. Vortex Spinix
16. Conical flask Qulaigens
17. Refrigerator LG
18. Electrophoresis tank Aplex
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5. METHODS
5.1 Collection of clinical isolated bacteria and antibiotic
The clinical isolated bacteria  Pseudomonas aeruginosa  and   Staphyloccocus
aureus  obtained from Vijay clinical  laboratory Madurai   and antibiotic  discs  used
ampicillin,  chloromphenicol,  ceftriaxone  and  roxithromycin  were  obtained  from
media, Mumbai.
5.2. Susceptibility 
Susceptibility tests were performed by Kirby Bauer technique ( Cappucino
2007 ) and the results were observed from Photo 1&2. 
Procedure
1. Agar plates was placed right  side up in an incubator heated to 37C for 10 to 20
minutes with covers adjust  so that the plates were slightly opened
2. Covers  of  each  plates  was  labeled  with  the  name  of  the  test  organism to  be
inoculated.
3. Using sterile technique ,all agar plate were  inoculated  with their respective test
organisms as follows:
A sterile cotton swab was dipped into a well –mixed saline test culture and
excess inoculum was removed by pressing the saturated swab against the inner wall of
the culture tube.
Using the swab, the entire agar surface was streaked horizontally, vertically,
and around the outer edge of the plates to ensure a heavy growth over entire surface.
4. All culture plates were allowed to dry for about 5 minutes.
5. Using the forceps the antibiotic disc were placed over the agar surface and pressed
gently to ensure that the disc adhere to the surface of the agar.
6. All plate culture were incubated in an inverted position for 24 hr at 37oC
7. Table  4  showed  the  susceptibility  of  isolated   microorganisms  to  various
antibiotic.
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5.3 .Minimum inhibitory concentration
The MIC was  performed by resazurin  microtitre  assay (Satyajit  D.  Sarker
2007) and results were tabulated in Table 5 and Photo 3, 4, 5 & 6.
Preparation of resazurin solution
The resazurin solution was prepared by dissolving 62 mg  in 10 mL of sterile
distilled water. A vortex mixer was used to obtain a well-dissolved and homogenous
solution.
Preparation of the plates
Plates  were prepared under  aseptic  conditions.  A sterile  96 well  plate  was
labelled. 
The  antibiotic  used  concentration  1mg/ml  and  perform  serial  dilution  0.5
Serial dilutions were performed using a multichannel pipette. To all wells add 100 ul
from the serially diluted antibiotics. To all wells 50 µL of nutrient broth was added
and tips discarded after use. To each well 10 µL of resazurin indicator solution was
added.
Finally, 10 µL of bacterial culture was added in and plates were plate wrapped
loosely with cling film to ensure that bacteria did not become dehydrated.
Control  plate  contain antibiotic  serially dilution +  broth + aline +indicator
(Satyajit D. Sarker 2007)
5.4 Plasmid DNA Preparation.
By alkaline lysis method.
1.5 ml of overnight culture centrifuge at 8000 rpm for 10 minutes, to the cell
pellets were resuspended in 90 L GTE buffer (50mM glucose, 25 mM Tris-HCl, pH
8.0and 10 mM EDTA). After an incubation period of 5 min at room temperature, the
cells  were lysed by adding 90L lysis buffer  (200 mM NaOH,1% sodium dodecyl
sulfate [SDS] PH.9).Samples were mixed and placed on ice for 5 min. The solution
was neutralized by adding 150 µL potassium acetate (KOAc) solution (5 M KOAc,
pH 4.8 or 5.5). Cell debris and chromosomal DNA were subsequently removed from
the  solution  by  centrifugation  (5  min  at10000  rpm).  Episomal  DNA was  further
purified by iso-propanol,  phenol /  chloroform extraction and ethanol precipitation.
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then dry the pellet and  suspend in 20 L of TE buffer(Simeon Oloni Kotchoni et al
2003,, , Thomas P. Quinn  et al 1997 )
5.5. Agarose gel electrophoresis
Agarose gel 0.8% was prepared in 100 mL 0.5 X TE buffer and boiled, this
was allowed to cool to 50ºC and 2 µL (1 mg/mL) of ethidium bromide was added.
The gel was poured and comb was inserted to make the walls. When the gel was set,
the comb was removed and the gel was placed in the gel box and immersed in 0.5 X
TE buffer. Samples were prepared by taking 10 µL of the DNA, 2 µL of loading dye.
Thegels  were run for  90 min at  50 Volt,  the gels  were viewed and photographed
(Photo 7) (Adel K K and  Sabiha, S.S 2010)
5.6. Competent cell 
5 ml of nutrient broth was inoculated with a single colony of  E.coli DH5α
(whose plasmid is manipulated genetically, plasmid less), incubated with shaking at
100 rpm for  24  hours  at  37°C,  then  1ml  of  bacterial  culture  was added  to10 ml
nutrient broth, incubated with shaking at 37°C, 100 rpm for 3-4 hours till OD become
0.3_o.5. The cells were harvested by centrifugation at 800 rpm, and then the pellet
resuspended  in 1.5 ml of cooled transformation calcium chloride keep in ice for 10
minutes and centrifuge at 500 rpm for 5 minute, , there suspended cell pellet in 1.5 ml
of calcium chloride left on ice for 10 minutes, centrifuged for 5minutes at the same
velocity,  and  resuspended  in  0.2ml  OD calcium  chloride  and  glycerol  and  store.
(Ameena SM Juma 2010)
5.7. Transformation process
2 µl of prepared plasmid DNA was added to the tube containing  of 100µl
competent cells. The mixture was placed on ice for 30 minutes, and then exposed to
heat  shock at  42°C for  2  minutes.  1ml  of  fresh nutrient  broth was then added to
transformation mixture and incubated at 37°C for 60 minutes to allow the expression
of antibiotic resistant genes.
To the nutrient agar added the antibiotic use (chloromphenicol and ampicillin )
and mixed well and then poured in plates to the plates streak or spread 0.1ml from the
transformation  mixture  in  nutrient  agar  contain  appropriate  antibiotic,  and  0.1  ml
competent cell and spread or streak on nutrient agar plates and the antibiotic  used as
control by using DH5 α . All plates were incubated at 37°C for 24 hours (Ameena S.
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M. Juma 2010). The colonies of transformed culture were observed after incubation
(Photo 8, 9, 10 & 11) and colony numbers were tabulated in Table 6.
5.8.Preliminary Efflux Pump Assay 
Accretion of Ethdium bromide:
By the  bacterial  isolate  in  use.  The  presence  of  antibiotic  use   was  done
according to Bacterial cells were spotted on solid Nutrient  agar  medium(control) and
Nutrient agar medium supplemented with 100 µg/ml of ethidium bromide. The plates
were examined under UV accrual of ethidium bromide in bacterial cells after 24 hr
incubation at 28o C (Laura Paixao 2009, Lăzăroaie MM 2009, Edward A et al 2012)
5.9. Ethidium bromide Accumulation Assay:
To determine the efflux pumps activity, the accumulation assay of Ethidium
bromide was performed with10 ml of early Log phase culture centrifuged and the
supernatant  was  discarded.  The  pellets  were  washed  twice  with  phosphate  buffer
saline (PBS) to remove the cell debris and other contaminants. Finally 10ml of PBS
was added to the pellet and vortexed well. 20µl of Ethidium bromide was taken from
stock  solution  (1mg/1ml),  added  to  the  10ml  of  bacterial  suspension  and  kept  in
rotrotary shaker at 150 rpm. At every 15 min interval, 1ml of culture was taken and
centrifuged at 10,000 rpm for 5 min. Cell free supernatant was taken and OD value
was measured at 600 nm ( Edward A et al 2012, Kunihiko Nishino et al  2004). The
accumulation plate were given in Photo 12, 13, 14 & 15 and results were tabulated in
Table 7 and Chart 1. 
5.10. Ethidium bromide Efflux Assay: 
To confirm the efflux pumps activity, the efflux assay was performed using
Ethidium  bromide.  10  ml  of  early  log  phase  culture  was  centrifuged  and  the
supernatant was discarded. The pellets were washed twice and suspended in 10ml of
PBS with increasing concentration of glucose (10, 50, 100 and 1000mM). 20µl of
Ethidium bromide stock solution (1mg/1ml) was added to the culture and shaken at
150 rpm for  1h.  At  every 15  min regular  interval,  1ml  of  culture  was taken  and
centrifuged at 10,000 rpm for 5 min 1ml of supernatant was taken and OD values
were observed at 600 nm (Kunihiko Nishino et al  2004, Edward.A, et al 2012).
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The effect of Glucose concentration in efflux pump assay were tabulated in
table.8,  and expressed in Chart  2&3 for  Staphyloccocus aureus  and  Pseudomonas
aeruginosa respectively.
6. RESULTS AND DISCUSSIONS
Infections  have  been  the  major  cause  of  disease  throughout  the  history of
human  population.  With  the  introduction  of  antibiotics,  it  was  thought  that  this
problem should disappear.  However,  bacteria  have been able to evolve to become
resistant to antibiotics (Senka D, and Jagoda et al 2007). It is clear that bacteria will
continue to develop resistance to currently available antibacterial drugs by either new
mutations or the exchange of genetic information, that is, putting old resistance genes
into new hosts (Fred C.Tenover 2006). Also the overwhelming use of antibiotics has
played a significant role in the outspread/emergence of antibiotic resistance bacteria.
Antibiotics added to animal-feed and given to livestock that are used as human food
contribute to additional resistance (Ashraf.R and Shah ,N.P 2011). In many healthcare
facilities  around  the  world,  bacterial  pathogens  that  express  multiple  resistance
mechanisms  are  becoming  the  norm,  complicating  treatment  and  increasing  both
human morbidity and financial  costs.  Prudent  use of  antibacterial  drugs using the
appropriate drug at the appropriate  dosage and for the appropriate duration is  one
important  means of  reducing the resistant  organisms to emerge.  New antibacterial
agents with different mechanisms of action are also needed. It is difficult to outsmart
organisms  that  have  had  several  billion  years  to  learn  how  to  adapt  to  hostile
environments, such as those containing antimicrobial agents.
In this experimental study the strains collected from clinical laboratory which
resist to get controlled through antibiotics used were considered to determine their
resistant  pattern  towards  the  respective  multiple  antibiotics.  Initially  the  selected
strains were screened for their susceptability towards the antibiotics listed herewith:
Ampicillin,  Chloramphenicol,  Ceftriaxone and  Roxithromycin  using disc  diffusion
method. The evaluation of components as antimicrobial substance can be carried out
by disc diffusion method described by Kirby Bauer. A standardized filter- paper disc-
agar  diffusion  procedure  is  known  as  Kirby  Bauer  technique,  which  allows
determining  the  drug  susceptibility  of  microorganisms  by  means  of  rapid
determination of the efficacy of drug by measuring the zone of inhibition diameter
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that results from diffusion of the agent into the medium surrounding the disc. In this
procedure,  filter  paper  discs  of  uniform  size  are  impregnated  with  specified
concentrations of different component and then placed on the surface of an agar plate
that has been seeded with the organism to be tested. The medium of choice is Muller
Hinton Agar, with a pH of 7.2-7.4, whichates  is aright gel where the different of drug
facilitate  carier  following incubation,  the  plates  are  examined for  the  presence  of
growth inhibition,  which is  indicated  by a  clear  zone  surrounding each  disc.  The
susceptibility of an organism to a drug is determined by the size of this zone, which
itself  is  dependent  on  variables  such  as,  the  ability  and  rate  of  diffusion  of  the
antibiotic into the medium and its interaction with the test organism, the number of
organisms inoculated, the growth rate of the organism, the degree of susceptibility of
the  organism  to  the  antibiotic.  A measurement  of  the  diameter  of  the  zone  of
inhibition in  millimeters  is  made,  and its  size is  compared  to  that  contained in  a
standardized chart NCCLS. Based on this comparison, the test organism is determined
to be resistant, intermediate, or susceptible to the antibiotic. 
  Pseudomonas aeruginosa  OCHM432 had antibiotic resistance of 62.5% to
all  the  tested  antibiotics  while  Enterobacter  aerogenes  OCHM11,  OCHM7,
Klebsiella  pneumoniae  OCHM26,  OCHM263,  Escherichia  coli  OCHM29  and
Shigella  dysenteriae OCHM39  had  the  lowest  antibiotic  resistance  of  12.5%.
(Adenike A  et al 2006). It is very well understood from the study that Pseudomonas
aeruginosa is developing resistance widely.
Staphylococcus  aureus  and  Staphylococcus  epidermidis were  found  to  be
sensitive against most of the antibiotics whereas  Staphylococcus aureus  show more
resistance  as  compare  to  Staphylococcus  epidermidis  (Asma basher  2007).  These
results  showed  the  emergence  of  antibiotic  resistance  by  microbes  in  diversified
geographical  accessions  and  particularly  by  Pseudomonas aeruginosa  and
Staphylococcus aureus. 
Table  4  clearly  depicts  that  ampicillin  is  resisted  by  P.aeuroginosa but
intermediate  to  chloramphenicol  and  chloramphenicol  is  resisted  by  S.aureus but
intermediate  to  ampicillin.  P.aeuroginosa  and S.aureus were  sensitive  to  both  the
ceftriaxone and roxithromycin. From these observations we decided to evaluate the
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minimum inhibitory concentration of these antibiotics to the selected strains. This was
done by rezasurin dye method.
Table 4: Susceptibility analysis
S. No Antibiotics
Zone of Inhibition (mm)
S. aureus P. aeuroginosa
1 Ampicillin 14.1 ± 0.10 7.83 ± 0.08
2 Chloramphenicol 11.45 ± 0.29 14.97 ± 0.09
3 Ceftriaxone 23.97 ± 0.15 17.03 ± 0.14
4 Roxithromycin 22.87 ± 0.09 24.03 ± 0.20
n=3, ± SEM
Photo 1 Photo 2
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S.  aureus sensitivity  assay  to  various
antibiotic
P. aeruginosa Sensitivity assay to 
various antibiotic
Resazurin is an oxidation–reduction indicator used for the evaluation of cell
growth, particularly in various cytotoxicity assays. It  is a blue non-fluorescent and
non-toxic  dye  that  becomes  pink  and  fluorescent  when  reduced  to  resorufin  by
oxidoreductases within viable cells. Resorufin is further reduced to hydroresorufin
(uncoloured and nonfluorescent). A resazurin reduction test has also been used for
decades to demonstrate bacterial and yeast contamination of milk (Sattyajit D,Sarker
et al 2007), here in this study resazurin dye purchased from himedia is utilized where
initial colour upon addition with culture showed blue. The colour change from blue to
pink shows the growth of microbe in the well and the colour change from blue to pink
indicate the minimum inhibitor concentration 
From  the  above  table  8,  we  could  observe  that  P.aeuroginosa is  highly
sensitive to ceftriaoxne (7.81µg/ml), chloramphenicol (7.81 µg/ml) and roxithromycin
(16.62 µg/ml) while S.aureus  is sensitive to ampicillin (7.81 µg/ml) alone. When we
compare  these  results  with  NCCLS  standards  it  is  clearly  understood  that  these
organisms started resisting the existing antibiotics.   It is mandatory to understand the
resisting pattern to combat these resisting factors. Mradula Singh 2009 reported that
the MIC levels  of  OFL showed 2-8 folds  reduction in  presence of  CCCP (16/45;
35.5%), verapamil (24/45; 53.3%) and DNP (21/45; 46.6%) while in case of isolates
identified as OFL sensitive these did not show any effect on ofloxacin MICs. In 11 of
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Table 5: Minimum inhibitory concentration (µg/ml)
S.No Antibiotic S. aureus P. aeuroginosa
1 Ampicillin 7.81 250
2 Chloramphenicol 0 7.81
3 Ceftriaxone 31.5 7.81
4 Roxithromycin 62.5 15.62
45 (24.5%) isolates change in MIC levels was observed with all the three inhibitors.
Overall  30 (66.6%) isolates had reduction in OFL MIC after treatment with these
inhibitors. Also we need to understand the transforming ability of plasmids to species.
This may be the most devastating reason to spread of resistance characters within the
bacteria in and around a specific region. So in this study we decided and performed
the  transformation  studies  of  resistance  making  plasmids  isolated  from  clinical
isolates resulting from sensitivity assay and MIC analysis.
 The effectiveness of this modified resazurin assay has been demonstrated with
methanol extracts of selected Scottish plants,  purified compounds and the positive
control  ciprofloxacin,  and  a  direct  comparison  of  the  MIC  determination  of  the
antibiotics  using  the  old  and  modified  resazurin  methods   using  the  antibiotics
norfloxacin, cefotaxime, and amoxicillin.( Satyajit D 2007).
The  result  shown  profound  to  accurate  value  on  repeated  assay  .By  this
method  seems  to  be  very  effective  in  determining  the  minimum  inhibitory
concentration of any compound or extract
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Minimum inhibitory concentration
Photo 3 Photo 4 
Photo 5 Photo 6 
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Photo 3- MIC of ceftriaxone (Right/ Black) and roxithromycin 
(Left/ Blue) 
against P. aeuroginosa
Photo 4- MIC of ceftriaxone (Right/ Black) and roxithromycin 
(Left/ Blue) 
against S. aeureus.
Photo 5- MIC of chloromphenicol (Left/ Black) against P. 
aeuroginosa and ampicillin (Right/Blue) against S. aeureus.
Photo 6- MIC of chloromphenicol (Left/ Black) against S. 
aeureus. and ampicillin (Right/Blue) against P. aeuroginosa.
A- 250µg/ml, B- 125 µg/ml, C- 62.5 µg/ml, D-31.25 µg/ml, E-
15.62 µg/ml, F-7.81 µg/ml, G- Control (Without antibiotic), H- 
Plasmid DNA isolation
The charaterization of the plasmid isolated from resistant bacteria was studied
by agarose gel electrophoresis.
From the photo 7,  lane 1 is  the marker DNA utilized having basepair size
ranging from 10-100 bp. Lane 2 represents plasmid isolate from P.aeuroginosa and
lane 3 depicts the plasmid isolated from S.aureus. the seperated plasmids showed high
molecular comparing to the marker DNA utilized.
Photo 7: Agarose Gel Electrophoresis
 Lane1
     ↓
Lane2 
    ↓
Lane 3
     ↓
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Lane 1: Marker DNA(10-100bp)
Lane 2: Plasmid from P.aeuroginosa
Lane 3:Plasmid from S.aureus
To  determined  that,  if  the  bacterial  resistant  to  antibiotic  is  encoded  by
plasmid DNA, by transformation process was performed with plasmid isolated from
P.aeruginosa and S.aurus and  E.coli DH5α strain The isolated plasmid DNA from P.
aeruginosa and S.aurus transferred successfully to E. coli DH5α strain.
Nizami  Duran  2007  reported  the  Methicillin  resistance  rate  among  139
Staphlococcus aureus isolates was 16.5 and 25.9 per cent of S. aureus carried mecA
gene. Of the 159 CoNS isolates, methicillin resistance rate was 18.9 and 29.6 per cent
carried  mecA  gene.  Ninety  four  isolates  identified  as  gentamicin  resistant
phenotypically,  contained  at  least  one  of  the  gentamicin  resistance  genes
[aac(6’)/aph(2’’),  aph(3’)-IIIa,  ant(4’)-Ia],  17  gentamicin-susceptible  isolates  were
found as positive in terms of one or more resistance genes [aac(6’)/aph(2’’), aph(3’)-
IIIa,  ant(4’)-Ia]  by  multiplex  PCR.  A  total  of  165  isolates  were  resistant  to
erythromycin, and contained at least one of the erythromycin resistance genes (ermA,
ermB, ermC and msrA). Phenotypically, 106 staphylococcal isolates were resistant to
tetracycline, 121 isolates carried either tetK or tetM or both resistance genes.  The
majority of staphylococci tested possessed the blaZ gene (89.9%).
Adel KK 2010 determined if the antibiotic resistance in isolated P. aeruginosa
is  encoded by plasmid DNA or chromosomal DNA transformation process.   They
performed the transformation process to the most resistant isolate of P. aeruginosa P8
and more sensitive isolate P1 and E. coli DH5" strain. Extracted plasmid DNA from
P. aeruginosa transferred successfully to E. coli DH5" strain. Ninety nine and thirty
six transforment colonies obtained for P1 and P8 isolates, respectively.
Table 6: No of colonies seen in Transformed plates
S.No Strains Coloni
es
1 Pseudomonas aeuroginosa transformed plasmid to DH5
α
26
47
2 Staphylococcus aureus transformed plasmid to DH5 α 24
Photo 8 Photo 9
Photo 10 Photo 11
48
Photo 8- Control plate (Transformation I) contains DH5α with ampicillin
Photo 9- Transformation I- Competent cells from DH5 α with plasmid DNA isolated
from P.aeuroginosa and ampicillin.
Photo 10- Control plate (Transformation II) contains DH5α with choloramphenicol
Photo 11- Transformation II- Competent cells from DH5 α with plasmid DNA isolated
from S.aeureus choloramphenicol.
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Efflux Pump Assay
Ethidium bromide Accumulation: 
The existence of antibiotic efflux pumps was analyzed by ethidium bromide
accumulation (1 µg•ml) in bacterial cells treated with test antibiotic by exploring the
fluorescence  of  Ethidium  bromide  bacteria  under  UV  light.  There  was  an
accumulation of Etidium bromide  in antibiotic treated  treated bacteria compared to
control when examined under UV light (photos.12,13,14,15.)
Edward A,et  al 2012  analysed  and repoted  the  existence  of  solvent  efflux
pumps was analyzed by rhodamine B accumulation (100 µg•ml) in bacterial  cells
treated with test solvents by exploring the fluorescence of Rhodamine B in bacteria
under  UV light.  Could  observed  clear  an  accumulation  of  Rhodamine  B  dye  in
organic solvents treated bacteria compared to control when examined under UV .from
this study they reported that the  frequent exposure of microbes to organic solvent
may induce the resistance pattern of microbes toward antibiotic.
 Gene deletion resulted in a drastic decrease in fluorescence, clearly indicating
the active efflux of these drugs from hns cells Accumulation of these drugs in E. coli
cells was observed from the fluorescence of ethidium bromide  and rhodamine 6G
under UV light. .(Kunihiko Nishino 2004)
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Photo 12 Photo 13
Photo 14 Photo 15
Photo 12- Control plate (S.aeureus with choloramphenicol) under UV 
transilluminator
Photo 13- Accumulation of ethidium bromide in S.aeureus existing with 
choloramphenicol under UV transilluminator.
Photo 14- Control plate (P.aeuroginosa with ampicillin) under UV 
transilluminator
Photo 15- Accumulation of ethidium bromide in P.aeuroginosa existing 
with ampicillin under UV transilluminator.
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Ethidium bromide Accumulation Assay
The accumulation assay was  performed to  determine  the  activity of  efflux
pumps  in  the  bacterial  cells.  Etidium  bromide  was  utilize  as  a  test  dye  for  the
accumulation  assay.  P.aeruginosa accumulation  dye  at  30  min  and  S.aureus
accumulating dye at 15th min, after which there was a sudden decline in the accrual of
dye till 45 min followed by  gradual increase and  decrease in the accumulation of dye
.(table 7 and chart .1)
Ethidium bromide efflux assay
P.aerginosa and s.aurus  has shown high efflux activity of Etidium bromide at
1000mM (glucose  containing PBS)  followed by 100,  50 and  10mM compared  to
control (glucose free PBS).  P.aerginosa  efflux activity was observed at 45th minute
and for S.aurus.  It was observed at 60th mn incubated with glucose has shown high
efflux activity compared to untreated.
           B. oleronius has shown high efflux activity of rhodamine B at 1000mM
(glucose  containing  PBS)  followed  by  100,  50  and  10mM  compared  to  control
(glucose  free  PBS).  B.  oleronius  incubated  with  glucose  has  shown  high  efflux
activity  compared  to  untreated.  Efflux  activity  was  observed  at  45  min  after  the
incubation(Edwar A, (2012). This above study coincides with our results upon the
glucose concentrations. 
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Table 7: Ethidium bromide accumulation assay
Table 8: Influence of Glucose concentration in efflux pump assay
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S. No Time
interval
(Min)
Glucose Concentration (mM)
10 50 100 1000
P.aeuro S.aureus P.aeuro S.aureu
s
P.aeuro S.aureu
s
P.aeuro S.aureu
s
1 0 0.34 0.25 0.17 0.10 0.22 0.15 0.25 0.20
2 15 0.11 0.18 0.18 0.13 0.30 0.20 0.20 0.23
3 30 0.19 0.15 0.22 0.12 0.17 0.17 0.25 0.18
4 45 0.26 0.11 0.25 0.10 0.16 0.22 0.45 o.15
5 60 0.12 0.13 0.19 0.11 0.13 0.09 0.23 0.38
6 75 0.10 0.08 0.12 0.12 0.18 0.16 0.16 0.27
7 90 0.08 0.05 0.11 0.07 0.12 0.10 0.14 0.13
8 105 0.09 0.10 0.20 0.10 0.18 0.08 0.19 0.22
9 120 0.06 0.13 0.20 0.15 0.15 0.21 0.10 0.10
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Chart No.2
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Exposure  to  biocides  and  dyes  are  commonly  employed  in  hospital  and
laboratory settings. Many of these agents are substrates for multiple-drug resistance
(MDR)-conferring  efflux  pumps  of  both  Gram-positive  and  Gram-negative
organisms. Several such pumps have been identified in  Staphylococcus aureus, and
mutants  overexpressing  the  NorA and  MepA MDR pumps  following  exposure  to
fluoroquinolones have been identified. Such problem is seen in many of the case s
related  to  resistant  to  antibiotic.  The  effect  of  exposure  to  low concentrations  of
biocides and dyes on the expression of specific pump genes has not been evaluated
(Aure lie A. Huet, Jose L. Raygada, (2008)). in this study we determined the efflux
activity of  staphylococcus aureus  and  Pseudomonas  aeruginosa as  such  and  their
increase ability with respect to glucose concentration. 
This  efflux  active  it  may be  due  to  over  expression  of  gens  which  resist
ampicillin and chloramphenicol. 
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7. SUMMARY AND CONCLUSIONS
Pseudomonas  aeruginosa and  Staphylococcus  aureus  is  an  opportunistic
pathogen  that  causes  human  infection;  and  they  showed  high  resistant  to  most
antibiotic (ampicillin, chloromphenicol), Transformation process results  derives us to
conclude  that  all  genes  responsible  for  antibiotic  resistant  in  Pseudomonas
aeruginosa  and Staphylococcus aureus from the findings of this study,  This has been
attributed to either the ability of these organisms to produce resistance mechanisms,
for this the characterization of plasmid DNA of  P.aeruginosa  and Staphylococcus
aureus isolates indicated that these two isolates transfer to another bacteria, in present
study to E. coli  DH5" strain.
Unfortunately, resistance in some species has developed to the level that no
clinically  available  treatment  is  effective.  Prevention  and  control  strategies  will
require the application of epidemiological and behavioural approaches, as well as the
research technologies aimed at the basic mechanisms of drug resistance. 
The genetic characterization of antimicrobial resistance genes as well as their
location and diversity is important in identifying factors involved in resistance. All the
alternative  strategies  to  overcome  resistance  require  expanded  knowledge  of  the
molecular mechanisms of antibiotic resistance, their origins and evolution, and their
distribution throughout bacterial populations and genomes.
Accumulation of  Ethidium bromide was  observed in  effluxing of  ethidium
bromide was more  in  glucose  treated  cells  than  control.  This  has  shown that  the
glucose has provided energy necessary to efflux ethidium bromide in and out of the
cells.
Ethidium  bromide  accumulation  and  efflux  activity  in  bacterial  isolates
divulged  the  critical  importance  of  efflux  pump  in  the  extrusion  of  harmful
compounds for the survival of bacteria under stressful environment.
Susceptibility  analysis  showed  the  Staphyloccocus  aureus  resistant  to
chloramphenicol and Pseudomonas aeruginosa to ampicillin.
The  Minimum  Inhibitory  Concentration  range  between  7.81to  62.25  for
ampicillin,  chloramphenicol,  roxithromycin  and  ceftriaxone  tested  against
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Staphyloccocus  aureus,  whereas  MIC  range  between  7.81  to  250  for
chloramohenicol,ceftriaxone,  roxithromycin  and  ampicillin  tested  against
Pseudomonas aeruginosa .
The  successful  transformation  was  done  and  26  colones  where  seen  in
transformed plate of Pseudomonas aeruginosa  and 24 colones in transformed plates
of Staphyloccocus aureus.
          The accumulation assay and the influence of glucose concentration in effluxing
ability  where  studied  and  optimum glucose  concentration  which  influence  efflux
ability was found was found at 1000 Mm, by this we conclude the clinical isolates
Pseudomonas aeruginosa  and  Staphyloccocus aureus  resistant  antibiotic ampicillin
and chloramphenicol respectively through two different mechanism and genes present
in plasmid. Either new drug moiety or modifications needed in existing antibiotics. 
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